UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A
(RULE 14A-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement | |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
☒ | Definitive Proxy Statement | |
☐ | Definitive Additional Materials | |
☐ | Soliciting Material Under § 240.14a-12 |
Diebold Nixdorf, Incorporated
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. | |||
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
(1) | Title of each class of securities to which transaction applies:
| |||
(2) | Aggregate number of securities to which transaction applies:
| |||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
(4) | Proposed maximum aggregate value of transaction:
| |||
(5) | Total fee paid:
| |||
☐ | Fee paid previously with preliminary materials. | |||
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
(1) | Amount Previously Paid:
| |||
(2) | Form, Schedule or Registration Statement No:
| |||
(3) | Filing Party:
| |||
(4) | Date Filed:
|
5995 Mayfair Road
P. O. Box 3077 North Canton, Ohio 44720-8077
March 14, 2018
Dear Shareholder:
The 2018 Annual Meeting of Shareholders of Diebold Nixdorf, Incorporated will be held at the Courtyard Marriott, 4375 Metro Circle NW, North Canton, Ohio 44720, on Wednesday, April 25, 2018 at 11:30 a.m. EDT.
As described in the accompanying Notice and Proxy Statement, at the Annual Meeting, you will be asked to (1) elect eleven directors, (2) ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2018, (3) approve, on an advisory basis, our named executive officer compensation, and (4) approve amendments to the Diebold Nixdorf, Incorporated 2017 Equity and Performance Incentive Plan.
We are pleased to continue to take advantage of the Securities and Exchange Commission rules allowing us to furnish proxy materials to shareholders on the Internet. We believe that these rules provide you with proxy materials more quickly and reduce the environmental impact of our Annual Meeting. Accordingly, we are mailing to shareholders a Notice of Internet Availability of Proxy Materials containing instructions on how to access and review our 2018 Proxy Statement and Annual Report for the year ended December 31, 2017, and to vote online or by telephone. If you would like to receive a paper copy of our proxy materials, please follow the instructions for requesting these materials on the Notice of Internet Availability of Proxy Materials.
All holders of record of Diebold Nixdorf, Incorporated common shares at the close of business on February 26, 2018 are entitled to vote at the 2018 Annual Meeting. You may vote online at www.proxyvote.com. If you received a paper copy of the proxy card by mail, you may also vote by signing, dating and mailing the proxy card promptly in the return envelope or by calling a toll-free number.
If you are planning to attend the meeting, directions to the meeting location are included on the back page. If you are unable to attend the meeting, you may listen to a replay that will be available on our website at http://www.dieboldnixdorf.com. The replay may be accessed on our website soon after the meeting and shall remain available for up to three months.
We look forward to seeing those of you who will be attending the meeting.
Sincerely,
GARY G. GREENFIELD
Chairman of the Board
|
GERRARD B. SCHMID
President and Chief Executive Officer
|
Important Notice Regarding the Availability of Proxy Materials for the
Annual Meeting of Shareholders to be held on April 25, 2018.
This Proxy Statement, along with our Annual Report for the year ended December 31, 2017, including exhibits,
are available free of charge at www.proxyvote.com (you will need to reference the 16-digit control number
found on your proxy card or Notice of Internet Availability of Proxy Materials in order to vote).
5995 Mayfair Road
P. O. Box 3077 North Canton, Ohio 44720-8077
NOTICE OF ANNUAL MEETING OF
SHAREHOLDERS
DATE: April 25, 2018
TIME: 11:30 a.m. EDT
LOCATION: Courtyard Marriott 4375 Metro Circle NW North Canton, Ohio 44720
|
ITEMS TO BE DISCUSSED:
| |||||
1.
|
To elect eleven directors;
| |||||
2. | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2018;
| |||||
3.
|
To approve, on an advisory basis, our named executive officer compensation; and
| |||||
4. | To approve amendments to the Diebold Nixdorf, Incorporated 2017 Equity and Performance Incentive Plan.
|
Your attention is directed to the attached Proxy Statement, which fully describes these items.
Any action on the items of business described above may be considered at the Annual Meeting at the time and on the date specified above or at any time and date to which the Annual Meeting may be properly adjourned or postponed.
Holders of record of Diebold Nixdorf, Incorporated common shares at the close of business on February 26, 2018 will be entitled to vote at the 2018 Annual Meeting.
The enclosed proxy card is solicited, and the persons named therein have been designated, by Diebold Nixdorfs Board of Directors.
By Order of the Board of Directors
| ||
Jonathan B. Leiken Senior Vice President, Chief Legal Officer and Secretary
|
March 14, 2018
(approximate mailing date)
You are requested to cooperate in assuring a quorum by voting online at www.proxyvote.com
or, if you received a paper copy of the proxy materials, by filling in, signing and dating the
enclosed proxy and promptly mailing it in the return envelope.
TABLE OF CONTENTS
|
ii | | 2018 PROXY STATEMENT |
This Proxy Statement is furnished to shareholders of Diebold Nixdorf, Incorporated (Diebold Nixdorf, the Company, we, our, and us) in connection with the solicitation by the Board of Directors of proxies to be used at our 2018 Annual Meeting of Shareholders, and any postponements or adjournments of the meeting.
These proxy materials are being sent to our shareholders on or about March 14, 2018.
This proxy summary is intended to provide an overview of the information you can find elsewhere in this Proxy Statement. As this is only a summary, we encourage you to read the Proxy Statement in its entirety for more information about these topics before voting.
MEETING INFORMATION
TIME AND DATE
11:30 a.m. EDT, April 25, 2018 |
PLACE
Courtyard Marriott 4375 Metro Circle NW North Canton, Ohio 44720
|
RECORD DATE
Close of Business on February 26, 2018 |
||||||||||||||||||
PROPOSALS FOR YOUR VOTE AND BOARD RECOMMENDATIONS
PROPOSAL
|
BOARD RECOMMENDATION
|
PAGE REFERENCES (FOR MORE DETAIL)
|
||||
1. To elect eleven directors
|
FOR EACH NOMINEE
|
|
18-24
|
| ||
2. To ratify the appointment of KPMG LLP as our independent registered publicaccounting firm
|
FOR
|
|
28
|
| ||
3. To approve, on an advisory basis, our named executive officer compensation
|
FOR
|
|
30, 42-84
|
| ||
4. To approve amendments to the Diebold Nixdorf, Incorporated 2017 Equity andPerformance Incentive Plan
|
FOR
|
|
31-41
|
|
Information on voting mechanics, approval requirements and related matters can be found in the Voting Information and Other Matters sections starting on pages 5 and 87, respectively.
2018 PROXY STATEMENT | | 1 |
PROXY SUMMARY
|
BUSINESS PERFORMANCE AND STRATEGIC INITIATIVES
CORPORATE GOVERNANCE UPDATES AND SHAREHOLDER OUTREACH
2 | | 2018 PROXY STATEMENT |
PROXY SUMMARY
|
OVERVIEW OF OUR BOARD NOMINEES
You are being asked to vote to elect each of the following nominees to our Board of Directors. The tables that follow provide summary information about our nominees, and detailed information about each director nominees background, skills and expertise can be found in Proposal 1: Election of Directors on pages 18-24.
Information about our Audit Committee, Board Governance Committee, Compensation Committee, Finance Committee, and Technology Strategy and Innovation Committee can be found on pages 9-10.
COMMITTEE MEMBERSHIP | ||||||||||||||||
NAME AND OCCUPATION / CAREER HIGHLIGHTS
|
AGE
|
DIRECTOR SINCE
|
INDEPENDENT
|
AUDIT
|
BOARD GOV.
|
COMP.
|
FIN.
|
TS&I
| ||||||||
Patrick W. Allender Retired Executive Vice President, Chief Financial Officer and Secretary, Danaher Corporation |
71 | 2011 | Yes | Chair | · | |||||||||||
Phillip R. Cox President and Chief Executive Officer, Cox Financial Corporation |
70 | 2005 | Yes | · | Chair | |||||||||||
Richard L. Crandall Managing Partner, Aspen Venture LLC; Executive Chairman, Pelstar LLC |
74 | 1996 | Yes | · | Chair | |||||||||||
Dr. Alexander Dibelius Managing Partner, CVC Capital Partners (Deutschland) GmbH |
58 | 2016 | Yes | · | · | |||||||||||
Dr. Dieter W. Düsedau Physicist and Former Director (Senior Partner), McKinsey & Co. |
59 | 2016 | Yes | · | · | |||||||||||
Gale S. Fitzgerald Retired President and Director, TranSpend, Inc. |
67 | 1999 | Yes | · | Chair | |||||||||||
Gary G. Greenfield Non-executive Chairman of the Board, Diebold Nixdorf, Incorporated; Partner, Court Square Capital Partners |
63 | 2014 | Yes | · | · | |||||||||||
Gerrard B. Schmid President and Chief Executive Officer, Diebold Nixdorf, Incorporated |
49 | 2018 | No | |||||||||||||
Rajesh K. Soin Chairman of the Board and Chief Executive Officer, Soin, LLC |
70 | 2012 | Yes | · | · | |||||||||||
Alan J. Weber Chief Executive Officer, Weber Group LLC |
69 | 2005 | Yes | · | Chair | |||||||||||
Dr. Juergen Wunram Senior Vice President and Chief Operating Officer, Diebold Nixdorf, Incorporated |
59 | 2017 | No |
2018 PROXY STATEMENT | | 3 |
PROXY SUMMARY
|
SNAPSHOT OF KEY QUALIFICATIONS AND SKILLS OF OUR NOMINEES
| ||||||||||||||||||||||||
International | 7 | |||||||||||||||||||||||
Technology/Innovation | 6 | |||||||||||||||||||||||
Financial Services | 8 | |||||||||||||||||||||||
Retail | 4 | |||||||||||||||||||||||
Leadership | 11 | |||||||||||||||||||||||
Corporate Governance | 8 | |||||||||||||||||||||||
Audit/Finance | 7 | |||||||||||||||||||||||
Govt Regulated Industries | 4 | |||||||||||||||||||||||
Director Tenure 0 to 5 Years 6 to 15 Years Over 15 Years See pages 15-16 for more information on our considerations of a director nominee and additional detail regarding the key qualifications and skills of our 2018 nominees. Information about our directors compensation and share ownership is provided on pages 13-14, 26-27. SNAPSHOT OF KEY QUALIFICATIONS AND SKILLS OF OUR NOMINEES International Technology/Innovation Financial Services Leadership Corporate Governance Audit/Finance Govt Regulated Industries 1 2 3 4 5 6 7 8 9 10 11
4 | | 2018 PROXY STATEMENT |
VOTING INFORMATION
|
6 | | 2018 PROXY STATEMENT |
CORPORATE GOVERNANCE
|
BOARD COMMITTEES AND COMPOSITION
The Boards current standing committees are the Audit Committee, Board Governance Committee, Compensation Committee, Finance Committee and Technology Strategy and Innovation Committee. Each committees members and meetings during 2017 and functions are described below.
AUDIT COMMITTEE* |
||
Members:
Patrick W. Allender (Chair), Dr. Dieter W. Düsedau, Gale S. Fitzgerald and Robert S. Prather, Jr.
All members of this committee qualify as independent.
Meetings:
This committee met in person or telephonically eleven times during 2017, and had informal communications with management, as well as with our independent auditors, at various other times during the year.
Contact:
auditchair@dieboldnixdorf.com
Committee Report: See page 85.
|
Primary Duties and Responsibilities:
Monitors the adequacy of our financial reporting process and systems of internal controls regarding finance, accounting and ethics and compliance.
Monitors the independence and performance of our outside auditors and performance and controls of our internal audit department.
Provides an avenue of communication among the outside auditors, management, the internal audit department and the Board.
Financial Experts:
The Board has determined that Mr. Allender is an audit committee financial expert within the meaning of such term under Item 407(d)(5) of Regulation S-K.
|
* | This committee is a separately-designated standing audit committee established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934 (the Exchange Act). |
BOARD GOVERNANCE COMMITTEE |
||
Members:
Gale S. Fitzgerald (Chair), Phillip R. Cox, Richard L. Crandall and Dr. Alexander Dibelius
All members of this committee qualify as independent.
Meetings:
This committee met in person or telephonically five times during 2017, and had informal communications with management at various other times during the year.
Contact:
bdgovchair@dieboldnixdorf.com
|
Primary Duties and Responsibilities:
Insures Board oversight of our enterprise risk management process.
Reviews qualifications of potential director candidates.
Makes recommendations to the Board to fill vacancies or consider the appropriate size of the Board.
Makes recommendations regarding corporate governance principles, Board committee composition, and the directors compensation for their services on the Board and on Board committees.
Leads and oversees all of the Board and Committee assessments.
Oversees director orientation and education, as described in Director Orientation and Education below.
|
2018 PROXY STATEMENT | | 9 |
CORPORATE GOVERNANCE
|
COMPENSATION COMMITTEE |
||
Members:
Phillip R. Cox (Chair), Dr. Dieter W. Düsedau, Rajesh K. Soin and Alan J. Weber
All members of this committee qualify as independent.
Meetings:
This committee met in person or telephonically five times during 2017, and had informal communications with management, as well as the committees independent compensation consultant, at various other times during the year.
Contact:
compchair@dieboldnixdorf.com
Committee Report: See page 42. |
Primary Duties and Responsibilities:
Administers our executive compensation program.
Oversees our equity plans (including reviewing and approving equity grants to executive officers).
Annually reviews and approves all pay decisions relating to executive officers.
Determines and measures achievement of corporate and individual goals, as applicable, by our executive officers under our short- (annual) and long-term incentive plans, and makes recommendations to the Board for ratification of such achievements.
Reviews the management succession plan and proposed changes to any of our benefit plans, such as retirement plans, deferred compensation plans and 401(k) plans.
For additional discussion of the committees role, processes and procedures in connection with executive compensation, see Compensation Discussion and AnalysisRole of the Compensation Committee below.
|
FINANCE COMMITTEE |
||
Members:
Alan J. Weber (Chair), Patrick W. Allender, Dr. Alexander Dibelius, Gary G. Greenfield and Robert S. Prather, Jr.
All members of this committee qualify as independent.
Meetings:
This committee met in person or telephonically six times in 2017, and had informal communications with management at various other times during the year. |
Primary Duties and Responsibilities:
Makes recommendations to the Board with respect to material or other significant transactions.
Oversees the Companys borrowing structures and credit facilities.
Establishes investment policies, including asset allocation, for our cash, short-term securities and retirement plan assets and oversees the management of those assets.
Reviews our financial exposure and liabilities, including the use of derivatives and other risk management techniques.
Makes recommendations to the Board related to customer financing activities and funding plans for our Company.
|
TECHNOLOGY STRATEGY AND INNOVATION COMMITTEE |
||
Members:
Richard L. Crandall (Chair), Gary G. Greenfield and Rajesh K. Soin
All members of this committee qualify as independent.
Meetings:
This committee met in person or telephonically two times in 2017 and had informal communications with management at various other times during the year. |
Primary Duties and Responsibilities:
Assists the Board in its oversight of our investment in software and services technology and intellectual property.
Evaluates our global technology and innovation strategies and initiatives, including their impact on our performance and competitive position.
Evaluates management proposals for strategic software and technology investments, divestitures, and acquisitions.
Provides clarification and validation to the Board on the direction of our Company as it relates to technology and innovation.
|
10 | | 2018 PROXY STATEMENT |
In addition to their annual retainers, our non-employee directors also received the following annual committee fees for their participation as members or as Chairs of one or more Board committees:
MEMBER
|
CHAIR
|
|||||||
Audit Committee
|
|
$12,500
|
|
|
$25,000
|
| ||
Compensation Committee
|
|
$10,000
|
|
|
$20,000
|
| ||
Board Governance Committee
|
|
$ 7,500
|
|
|
$15,000
|
| ||
Finance Committee
|
|
$ 7,500
|
|
|
$15,000
|
| ||
Technology Strategy and Innovation Committee
|
|
$ 7,500
|
|
|
$15,000
|
|
2018 PROXY STATEMENT | | 13 |
COMPENSATION OF DIRECTORS
|
The following table details the compensation of our non-employee directors for 2017:
NAME | FEES EARNED OR PAID IN CASH1 ($) |
STOCK AWARDS2 ($) |
ALL OTHER COMPENSATION3 ($) |
TOTAL ($) | ||||||||||||||||
Patrick W. Allender
|
|
104,167
|
|
|
148,723
|
|
|
8,824
|
|
|
261,714
|
| ||||||||
Phillip R. Cox
|
|
99,167
|
|
|
148,723
|
|
|
10,220
|
|
|
258,110
|
| ||||||||
Richard L. Crandall
|
|
94,167
|
|
|
148,723
|
|
|
10,812
|
|
|
253,702
|
| ||||||||
Dr. Alexander Dibelius
|
|
86,667
|
|
|
148,723
|
|
|
1,549
|
|
|
236,939
|
| ||||||||
Dr. Dieter W. Düsedau
|
|
94,167
|
|
|
148,723
|
|
|
1,549
|
|
|
244,439
|
| ||||||||
Gale S. Fitzgerald
|
|
99,167
|
|
|
148,723
|
|
|
12,824
|
|
|
260,714
|
| ||||||||
Gary G. Greenfield
|
|
86,667
|
|
|
148,723
|
|
|
2,450
|
|
|
237,840
|
| ||||||||
Robert S. Prather, Jr.
|
|
91,667
|
|
|
148,723
|
|
|
6,444
|
|
|
246,834
|
| ||||||||
Rajesh K. Soin
|
|
89,167
|
|
|
148,723
|
|
|
4,980
|
|
|
242,870
|
| ||||||||
Henry D. G. Wallace
|
|
171,667
|
|
|
148,723
|
|
|
13,664
|
|
|
334,054
|
| ||||||||
Alan J. Weber
|
|
96,667
|
|
|
148,723
|
|
|
10,060
|
|
|
255,450
|
|
1 | This column reports the amount of cash compensation earned in 2017 for Board and committee service, including Board retainer amounts discussed above and the following committee fees earned in 2017. |
NAME | AUDIT COMMITTEE ($) |
BOARD GOVERNANCE COMMITTEE ($) |
COMPENSATION COMMITTEE ($) |
FINANCE COMMITTEE ($) |
TECHNOLOGY STRATEGY & INNOVATION COMMITTEE ($) | ||||||||||||||||||||
Patrick W. Allender
|
|
25,000
|
|
|
|
|
|
|
|
|
7,500
|
|
|
|
| ||||||||||
Phillip R. Cox
|
|
|
|
|
7,500
|
|
|
20,000
|
|
|
|
|
|
|
| ||||||||||
Richard L. Crandall
|
|
|
|
|
7,500
|
|
|
|
|
|
|
|
|
15,000
|
| ||||||||||
Dr. Alexander Dibelius
|
|
|
|
|
7,500
|
|
|
|
|
|
7,500
|
|
|
|
| ||||||||||
Dr. Dieter W. Düsedau
|
|
12,500
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
| ||||||||||
Gale S. Fitzgerald
|
|
12,500
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Gary G. Greenfield
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
7,500
|
| ||||||||||
Robert S. Prather, Jr.
|
|
12,500
|
|
|
|
|
|
|
|
|
7,500
|
|
|
|
| ||||||||||
Rajesh K. Soin
|
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
7,500
|
| ||||||||||
Henry D. G. Wallace
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Alan J. Weber
|
|
|
|
|
|
|
|
10,000
|
|
|
15,000
|
|
|
|
|
2 | This column represents the aggregate grant date fair value computed in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 718 for RSUs granted to our non-employee directors in 2017, as further described above. Each director received 5,164 RSUs as of April 26, 2017, valued based on the closing price of our common shares on that date of $28.80. |
3 | This column represents dividend equivalents paid in cash on shares deferred by our directors. |
14 | | 2018 PROXY STATEMENT |
PROPOSAL 1: ELECTION OF DIRECTORS
BOARD RECOMMENDATION
✓
|
FOR the election of each of our director nominees
|
If for any reason any director-nominee is not available for election when the election occurs, the Proxy Committee, at its option, may vote for substitute nominees recommended by the Board. Alternatively, the Board may reduce the number of director-nominees. The Board has no reason to believe that any director-nominee will be unavailable for election when the election occurs.
OUR DIRECTOR NOMINEES
Patrick W. Allender
| ||
AGE: 71
DIRECTOR SINCE 2011
COMMITTEES: Audit Committee (Chair) Finance Committee |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Mr. Allender retired in February 2007 as Executive Vice President, Chief Financial Officer and Secretary for Danaher Corporation, Washington, D.C. (a diversified manufacturing company).
He currently is a director of Brady Corporation, Milwaukee, Wisconsin (an identification solutions company), where he has served since 2007 and where he serves as Chair of the Finance Committee and as a member of the Audit and Corporate Governance Committees. Mr. Allender also is a director of Colfax Corporation, Annapolis, Maryland (a diversified manufacturing company), where he has served since 2008 and where he serves as Chair of the Nominating and Corporate Governance Committee and as a member of the Audit Committee.
DIRECTOR QUALIFICATIONS: Mr. Allenders 18 years as chief financial officer of a large publicly traded company with global operations provides our Board with valuable expertise in financial reporting and risk management. In addition, as a result of Mr. Allenders public accounting background, including as audit partner of a major accounting firm, he is exceptionally qualified to serve as Chair of our Audit Committee and a member of our Finance Committee.
|
18 | | 2018 PROXY STATEMENT |
PROPOSAL 1: ELECTION OF DIRECTORS
|
Phillip R. Cox
| ||
AGE: 70
DIRECTOR SINCE 2005
COMMITTEES: Compensation Committee (Chair) Board Governance Committee |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Mr. Cox has served as President and Chief Executive Officer of Cox Financial Corporation, Cincinnati, Ohio (a financial planning and wealth management services firm) since 1972.
Mr. Cox currently is a director of Cincinnati Bell Inc., Cincinnati, Ohio (a telecommunications company), where he has served as a director since 1993 and as Chairman of the Board since 2003, and where he serves as a member of the Audit and Finance, Compensation, and Governance and Nominating Committees and as the Chair of the Executive Committee. He also serves as a director of Touchstone Investments, Cincinnati, Ohio (a mutual fund company), where he has served since 1993 and where he has served as Chairman of the Board since 2008. Mr. Cox has been a director of TimkenSteel, Canton, Ohio (an engineered steel products company), since 2014 and serves as a member of the Audit and Compensation Committees. Prior to TimkenSteel becoming an independent company, Mr. Cox served as a director of The Timken Company, Canton, Ohio (an engineered steel products company), and was a member of the Audit Committee from 2004-2016, and Chair of the Finance Committee from 2004-2011.
DIRECTOR QUALIFICATIONS: Mr. Coxs 45 years of experience as a president and chief executive officer in the financial services industry, as well as his experience as a director on the boards of several government-regulated businesses, a global manufacturing company, and the Federal Reserve Bank of Cleveland, provides our Board with experience relevant to many key aspects of our business. Mr. Coxs experience as a chief executive officer also imparts appropriate insight into executive compensation and succession planning issues that are ideal for the Chairman of our Compensation Committee, and his extensive experience serving on public company boards of directors provides the understanding necessary to serve on our Board Governance Committee.
|
2018 PROXY STATEMENT | | 19 |
PROPOSAL 1: ELECTION OF DIRECTORS
|
Richard L. Crandall
| ||
AGE: 74
DIRECTOR SINCE 1996
COMMITTEES: Technology Strategy and Innovation Committee (Chair) Board Governance Committee |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Mr. Crandall is Managing Partner of Aspen Venture LLC, Aspen, Colorado (a venture capital and private equity firm), in which role he has served since 2001, and Executive Chairman of Pelstar LLC, Chicago, Illinois (a medical equipment manufacturing and sales company), in which role he has served since 2007. He is also the Chairman of the Enterprise Software Roundtable, Aspen, Colorado (a CEO roundtable for the software industry), and has served in that capacity since 1995.
Mr. Crandall currently is the Chairperson of the Board and a member of the Corporate Responsibility and Governance Committee of Donnelley Financial Solutions, Inc., Chicago, Illinois (a financial communications and data services company). Mr. Crandall formerly was a director of R.R. Donnelley & Sons Company, Chicago, Illinois (an interactive communications provider), where he served from 2012-2016 and was a member of the Governance, Responsibility and Technology Committee. In addition, Mr. Crandall is a director and member of the Governance Committee and chairs the Cyber Committee of the Board of the National Cybersecurity Center, Colorado Springs, Colorado (a public/private research and education partnership for cybersecurity), where he has served since 2016. Mr. Crandall formerly was a director of Novell, Inc. (an infrastructure software company) from 2003-2011, where he served as Chairman of the Board from 2008-2011. He also formerly was a director of Claymore Dividend & Income Fund, Lisle, Illinois (a management investment company), from 2004-2010 and of Platinum Energy Solutions, Houston, Texas (an energy services company), from 2012-2013.
DIRECTOR QUALIFICATIONS: Mr. Crandalls extensive experience as an entrepreneur, leader and board member with several companies in the information technology and technology fields, and in the financial industry, including serving as chairman of a $900 million global information technology business, brings diversity of thought and governance experience to our Board. Further, during his 20 years on our Board, Mr. Crandall has provided immeasurable assistance to our technology-driven businesses. Mr. Crandalls background in the financial services industry also provides important financial and investment expertise, and his information technology experience provides perspective on cybersecurity, technology risks and technology-related strategies.
|
20 | | 2018 PROXY STATEMENT |
PROPOSAL 1: ELECTION OF DIRECTORS
|
Dr. Alexander Dibelius
| ||
AGE: 58
DIRECTOR SINCE 2016
COMMITTEES: Board Governance Committee Finance Committee |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Dr. Dibelius is Managing Partner of CVC Capital Partners (Deutschland) GmbH (a private equity advisor), in which capacity he has served since 2015. Previously, he served in a number of capacities at Goldman Sachs from 1993 until 2015, including Chairman of the Executive Board of Goldman Sachs AG (a financial services company) from 2002-2015, and Global Chairman of the Investment Banking Division of Goldman Sachs, Inc. from 2013-2015. Prior to this, he worked as a consultant for McKinsey & Co. (a global management consulting firm), where he was appointed partner in 1992. Before his career in business, Dr. Dibelius was a surgeon at the University Clinic of Freiburg.
Dr. Dibelius also is Chairman and a member of the supervisory board of Diebold Nixdorf AG, a member of the supervisory board of KION Group AG, Wiesbaden (a fork lift manufacturing company), chairman of the board of Breitling SA, Switzerland (a luxury watch manufacturer), a member of the supervisory board of Douglas AG (a perfumery retail company) (as well as a member of the supervisory boards of Douglas GmbH, Düsseldorf, and Douglas Holding, Düsseldorf), a member of the supervisory board of Kirk Beauty Investments SA, Luxemburg, a member of the board of CVC Capital Partners Luxembourg SARL, Luxemburg, and a member of the shareholders committee of Tipico Group Ltd., Malta.
DIRECTOR QUALIFICATIONS: Dr. Dibelius over twenty years of experience in the investment and merchant banking sectors and his management consulting experience bring important expertise and insight to our Board. His historical knowledge from, and continued service leading, the Diebold Nixdorf AG supervisory board provides an invaluable perspective to our Board.
|
Dr. Dieter W. Düsedau
| ||
AGE: 59
DIRECTOR SINCE 2016
COMMITTEES: Audit Committee Compensation Committee |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Dr. Düsedau is a physicist and formerly a Director (Senior Partner) of McKinsey & Co. (a global management consulting firm) from 1988-2014, based in Munich. He was the leader of the German Strategy Practice and was the long-standing leader of McKinseys Telecoms, IT, and Media Sector in Germany. Prior to joining McKinsey, he worked at the Max Planck Institute, CERN (the European Organization for Nuclear Research), The University of Michigan, Ann Arbor, and M.I.T. on quantum field theories.
Dr. Düsedau also is a member of the supervisory board of Diebold Nixdorf AG and a member of the supervisory board of Kontron AG (an embedded computing technology company).
DIRECTOR QUALIFICATIONS: Dr. Düsedaus experience as a senior partner of a top management consulting firm, and his years of experience leading its strategy practice and telecommunications, IT, and media industry sectors, provide helpful insight and strengthen our Boards proficiencies in these areas. He also brings significant transactional experience to our Board, and his historical knowledge from and continued service on the Diebold Nixdorf AG supervisory board provides an invaluable perspective to our Board.
|
2018 PROXY STATEMENT | | 21 |
PROPOSAL 1: ELECTION OF DIRECTORS
|
Gale S. Fitzgerald
| ||
AGE: 67
DIRECTOR SINCE 1999
COMMITTEES: Board Governance Committee (Chair) Audit Committee |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Ms. Fitzgerald retired in December 2008 as President and Director of TranSpend, Inc., Bernardsville, New Jersey (a total spend optimization firm).
She currently is a director of Cross Country Healthcare, Inc., Boca Raton, Florida (a healthcare staffing company), where she has served since 2007 and where she serves as Chair of the Governance and Nominating Committee and a member of the Audit Committee. She is a former director of Health Net, Inc., Woodland Hills, California (a managed healthcare company), where she served from 2001-2016 and was Chair of the Finance Committee and a member of the Audit Committee.
DIRECTOR QUALIFICATIONS: Ms. Fitzgeralds international experience as chief executive officer in the information technology industry, chief executive officer of a business unit of International Business Machines and the president and chief executive officer of two privately-held consulting companies brings a well-rounded and diverse perspective to our Board discussions and provides significant insight in critical areas that impact our Company, including information technology, supply chain management, procurement solutions, human resources and compensation, strategic planning and operations management. With over 20 years of multiple board and committee experiences, Ms. Fitzgerald provides valuable insight to our Board processes and deliberations, and she provides a unique point of view as Chairperson of our Board Governance Committee and a member of our Audit Committee.
|
Gary G. Greenfield
| ||
AGE: 63
DIRECTOR SINCE 2014
COMMITTEES: Chairman of the Board Finance Committee Technology Strategy and Innovation Committee |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Mr. Greenfield is the non-executive Chairman of the Board of Diebold Nixdorf, Incorporated, in which capacity he has served since January 1, 2018. Mr. Greenfield serves as a Partner for Court Square Capital Partners, New York, New York (a private equity company), and has served in that role since 2013. He was Chairman, CEO and President of Avid Technology, Inc., Burlington Massachusetts (a digital media and entertainment company), from 2007-2013.
Mr. Greenfield is currently a director of Donnelley Financial Solutions, Inc., Chicago, Illinois (a financial communications and data services company), where he has served since October 2016 and is the Chairperson of the Compensation Committee and a member of the Audit Committee. He formerly was a director of Vocus, Inc., Beltsville, Maryland (a marketing and public relations software company), where he served as Chair of the Nominating and Governance Committee from 2008-2014, and of Epocrates, Inc., San Mateo, California (a company providing clinical content, practice tools and health industry engagement at the point of care), from 2011-2013.
DIRECTOR QUALIFICATIONS: Mr. Greenfields proven senior executive experience in high technology industries, coupled with his exceptional ability to grow markets, both domestic and international, and develop products, provides our Board with experience relevant to many key aspects of our business. Mr. Greenfields strong skills at developing company vision and strategies in the evolving software development field strengthen the proficiency of our Board in this area.
|
22 | | 2018 PROXY STATEMENT |
PROPOSAL 1: ELECTION OF DIRECTORS
|
Gerrard B. Schmid
| ||
AGE: 49
DIRECTOR SINCE 2018
President and Chief Executive Officer |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Mr. Schmid is the President and Chief Executive Officer of Diebold Nixdorf, Incorporated and has served in this capacity since February 2018. He was Chief Executive Officer of D+H Corporation (a global fintech company), from 2012-2017 and was President and CEO of D+Hs Filogix business unit (a mortgage and real estate technology service provider) from 2007-2012.
DIRECTOR QUALIFICATIONS: As President and Chief Executive Officer of our Company, Mr. Schmids day-to-day leadership provides him with intimate knowledge of our operations, which are a vital component of our Board discussions.
|
Rajesh K. Soin
| ||
AGE: 70
DIRECTOR SINCE 2012
COMMITTEES: Compensation Committee Technology Strategy and Innovation Committee |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Mr. Soin is Chairman of the Board and Chief Executive Officer of Soin, LLC, West Carrollton, Ohio (an investment holding company), and has held those positions since 1998. He served as Chairman of the Board and Chief Executive Officer of MTC Technologies, Inc. (a military defense systems company), from 2002-2008.
DIRECTOR QUALIFICATIONS: Mr. Soins experience as an entrepreneur is a tremendous asset. Mr. Soin has extensive experience in India, where we continue to focus on growth in its emerging market, and his engineering and software development background brings additional technical expertise to our Board. Further, Mr. Soins significant government contracting experience as the founder and Chairman of MTC Technologies Inc., a NASDAQ listed company before being acquired by BAE Systems, provides additional perspective in helping us grow our security business.
|
2018 PROXY STATEMENT | | 23 |
PROPOSAL 1: ELECTION OF DIRECTORS
|
Alan J. Weber
| ||
AGE: 69
DIRECTOR SINCE 2005
COMMITTEES: Finance Committee (Chair) Compensation Committee |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Mr. Weber is the Chief Executive Officer of Weber Group LLC, Greenwich, Connecticut (an investment advisory firm). He was Chairman and Chief Executive Officer of US Trust, Inc. (a banking and trust company) from 2002-2005 and an Operating Partner of Arsenal Capital Partners, LLC, New York, New York (a private equity firm) from 2009-2013.
Mr. Weber currently is a director of Broadridge Financial Solutions, Inc., Lake Success, New York (an investor communications, securities processing, and outsourcing company), where he has served since 2007 and where he serves as a member of the Audit Committee, and as Chairman of the Compensation Committee. He is also Chairman of KGS-Alpha Capital Markets, Inc. (a fixed income broker dealer), a director and Treasurer of DCTV (a charitable organization), and a director of Street Diligence LLC (a Fintech company). He also is a former director of Sandridge Energy, Inc., Oklahoma City, Oklahoma (an energy exploration and production company), where he served from 2013-2016 and was Chairman of the Nominating and Governance Committee.
DIRECTOR QUALIFICATIONS: Mr. Webers experience as a chief executive officer and chief financial officer in the financial industry, as well as his 27 years of experience at Citibank, including 10 years as an Executive Vice President, provides a tremendous depth of knowledge of our customers and our industry. Further, Mr. Webers experience as Chief Financial Officer of Aetna, Inc., an insurance services company, brings extensive financial expertise to our Finance Committee.
|
Dr. Juergen Wunram
| ||
AGE: 59
DIRECTOR SINCE 2017
Senior Vice President and Chief Operating Officer |
PRINCIPAL OCCUPATION, PROFESSIONAL AND BOARD EXPERIENCE: Dr. Juergen Wunram is Senior Vice President and Chief Operating Officer of Diebold Nixdorf, Incorporated, and has served in that capacity since February 16, 2017. He also acted as our Interim Co-President and Co-CEO from December 2017 to February 2018. Prior to this, he served as our Companys Senior Vice President and Chief Integration Officer. Dr. Wunram also currently serves as Chief Executive Officer and President of Diebold Nixdorf AG, a position he has held since April 1, 2017. He previously served as the Chief Financial Officer of Diebold Nixdorf AG from 2007-2017 and has been a member of the management board of Diebold Nixdorf AG since 2007.
DIRECTOR QUALIFICATIONS: As Chief Operating Officer of the Company, Dr. Wunrams responsibilities, which include integration, the Companys EMEA and retail businesses, the Companys subsidiary, AEVI International GmbH, as well as IT, security, quality and indirect procurement, provide him with intimate knowledge of our operations that are a vital component of our Board discussions. In addition, his role as CEO of Diebold Nixdorf AG provides an invaluable perspective to our Board.
|
24 | | 2018 PROXY STATEMENT |
BENEFICIAL OWNERSHIP OF SHARES
To our knowledge, no person beneficially owned more than five percent of our outstanding common shares as of December 31, 2017, except for the shareholders listed below. The information provided below was derived from reports filed with the SEC by the beneficial owners on the dates indicated in the footnotes below.
TITLE OF CLASS
|
NAME AND ADDRESS OF BENEFICIAL OWNER
|
AMOUNT AND NATURE OF BENEFICIAL OWNERSHIP
|
PERCENT OF CLASS
| |||||||||
Common Shares |
BlackRock, Inc. 55 East 52nd Street New York, New York 10055
|
|
7,767,6261
|
|
|
10.23
|
%
| |||||
Common Shares |
SouthernSun Asset Management, LLC 175 Toyota Plaza, Suite 800 Memphis, TN 38103
|
|
6,974,7592
|
|
|
9.18
|
%
| |||||
Common Shares |
Atlantic Investment Management, Inc. 666 Fifth Avenue New York, New York 10103
|
|
6,100,0003
|
|
|
8.03
|
%
| |||||
Common Shares |
The Vanguard Group 100 Vanguard Blvd. Malvern, Pennsylvania 19355
|
|
6,083,9884
|
|
|
8.01
|
%
| |||||
Common Shares |
GAMCO Investors, Inc., et al. One Corporate Center Rye, New York 10580
|
|
5,659,9975
|
|
|
7.45
|
%
|
1 | Information regarding share ownership was obtained from the Schedule 13G/A filed on January 19, 2018 by BlackRock, Inc. BlackRock, Inc. has sole voting power over 7,613,771 of our common shares and sole dispositive power over 7,767,626 of our common shares. BlackRock, Inc. is the parent company of the following subsidiaries that beneficially own our common shares: BlackRock Life Limited, BlackRock Advisors, LLC, BlackRock Investment Management (UK) Limited, BlackRock Asset Management Canada Limited, BlackRock Investment Management (Australia) Limited, BlackRock (Netherlands) B.V., BlackRock Fund Advisors, BlackRock Asset Management Ireland Limited, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., BlackRock Asset Management Schweiz AG, and BlackRock Investment Management, LLC. BlackRock Fund Advisors is the only BlackRock, Inc. subsidiary whose interest in our common shares is more than 5% of our common shares outstanding. |
2 | Information regarding share ownership was obtained from the Schedule 13G filed on February 14, 2018 by SouthernSun Asset Management, LLC. SouthernSun Asset Management, LLC has sole voting power over 6,477,919 of our common shares and sole dispositive power over 6,974,759 of our common shares. |
3 | Information regarding share ownership was obtained from the Schedule 13D/A filed on March 7, 2018 by Atlantic Investment Management, Inc. Atlantic Investment Management, Inc. has sole voting power over 5,248,987 of our common shares and sole dispositive power over 6,100,000 of our common shares. Atlantic Investment Management, Inc. serves as the investment advisor and has sole voting power over 5,248,987 of our common shares and sole dispositive power over all of our common shares owned by the following parties: (i) AJR International Master Fund, Ltd., a British Virgin Islands company, owns 401,355 of our common shares; (ii) Cambrian Master Fund, Ltd., a British Virgin Islands company, owns 3,000,225 of our common shares; (iii) Cambrian Global Master Fund, Ltd., a British Virgin Islands company, owns 1,205,552 of our common shares; and (iv) 1,492,838 of our common shares are held in one or more other accounts. |
4 | Information regarding share ownership was obtained from the Schedule 13G/A filed on February 9, 2018 by The Vanguard Group. The Vanguard Group has sole voting power over 148,537 of our common shares, shared voting power over 8,402 of our common shares, sole dispositive power over 5,933,659 of our common shares, and shared dispositive power over 150,329 of our common shares. Vanguard Fiduciary Trust Company, a wholly-owned subsidiary of The Vanguard Group, is the beneficial owner of 141,927 of our common shares or .15% of our common shares outstanding, as a result of its serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd., a wholly-owned subsidiary of The Vanguard Group, is the beneficial owner of 15,012 of our common shares or .01% of our common shares outstanding, as a result of its serving as investment manager of Australian investment offerings. |
5 | Information regarding share ownership was obtained from the Schedule 13D/A filed jointly by GAMCO Investors Inc., et al, on November 22, 2016. The entities of GAMCO Investors Inc., et al., that hold our common shares reported their beneficial ownership as follows: (i) Gabelli Funds, LLC has sole voting and dispositive power over 1,703,500 of our common shares; (ii) GAMCO Asset Management Inc. has sole voting power over 3,657,097 of our common shares and sole dispositive power over 3,867,697 of our common shares; (iii) MJG Associates, Inc. has sole voting and dispositive power over 4,500 of our common shares; (iv) Gabelli Foundation, Inc. has sole voting and dispositive power over 1,500 of our common |
2018 PROXY STATEMENT | | 25 |
|
shares; (v) MJG-IV Limited Partnership has sole voting and dispositive power over 5,000 of our common shares; (vi) GGCP, Inc. has sole voting and dispositive power over 16,000 of our common shares; (vii) GAMCO Investors, Inc. has sole voting and dispositive power over 200 of our common shares; and (viii) Mario J. Gabelli has sole voting and dispositive power over 61,600 of our common shares. |
SECURITY OWNERSHIP OF DIRECTORS AND MANAGEMENT
The following table shows the beneficial ownership of the Companys common shares, including those shares that individuals have a right to acquire (for example, through exercise of options) within the meaning of Rule 13d-3(d)(1) under the Exchange Act, by (1) each director and nominee, (2) each of our named executive officers, and (3) all directors and executive officers as a group as of February 26, 2018. Ownership is also reported as of that date for shares in the 401(k) Savings Plan over which the individual has voting power, together with shares held in our Employee Stock Purchase Plan.
DIRECTORS AND NOMINEES: |
COMMON SHARES BENEFICIALLY OWNED1 |
STOCK OPTIONS EXERCISABLE |
PERCENT OF CLASS | ||||||||||||
Patrick W. Allender
|
|
3,162
|
|
|
|
|
|
*
|
| ||||||
Phillip R. Cox
|
|
5,164
|
|
|
|
|
|
*
|
| ||||||
Richard L. Crandall
|
|
22,453
|
|
|
|
|
|
*
|
| ||||||
Dr. Alexander Dibelius
|
|
5,164
|
|
|
|
|
|
*
|
| ||||||
Dr. Dieter W. Düsedau
|
|
|
|
|
|
|
|
*
|
| ||||||
Gale S. Fitzgerald
|
|
18,251
|
|
|
|
|
|
*
|
| ||||||
Gary G. Greenfield
|
|
16,364
|
|
|
|
|
|
*
|
| ||||||
Robert S. Prather
|
|
20,564
|
2
|
|
|
|
|
*
|
| ||||||
Gerrard B. Schmid
|
|
|
3
|
|
|
|
|
*
|
| ||||||
Rajesh K. Soin
|
|
19,364
|
|
|
|
|
|
*
|
| ||||||
Henry D.G. Wallace
|
|
49,114
|
2
|
|
|
|
|
*
|
| ||||||
Alan J. Weber
|
|
17,864
|
|
|
|
|
|
*
|
| ||||||
Named Executive Officers:
|
|||||||||||||||
Dr. Juergen Wunram
|
|
4,913
|
3
|
|
25,118
|
|
|
*
|
| ||||||
Christopher A. Chapman
|
|
30,773
|
3,4
|
|
137,864
|
|
|
*
|
| ||||||
Andreas W.
Mattes5
|
|
207,078
|
|
|
852,848
|
|
|
1.38
|
%
| ||||||
Jonathan B. Leiken
|
|
14,921 |
3 |
|
53,409
|
|
|
*
|
| ||||||
Dr. Ulrich Näher
|
|
3,919
|
3
|
|
16,550
|
|
|
*
|
| ||||||
Olaf Heyden
|
|
3,919
|
3
|
|
16,550
|
|
|
*
|
| ||||||
Eckard
Heidloff5
|
|
|
|
|
|
|
|
|
| ||||||
All Current Directors and Current Executive Officers as a Group(18)
|
|
253,984
|
|
|
310,608
|
|
|
*
|
|
* | Less than 1% |
1 | Director amounts do not include shares deferred by our non-employee directors under the Deferred Compensation Plan No. 2 for Directors. The amounts of such deferred shares are: Mr. Allender, 23,352; Mr. Cox, 20,550; Mr. Crandall, 20,900; Dr. Düsedau, 5,164; Ms. Fitzgerald, 33,352; Mr. Soin, 7,450; and Mr. Weber, 20,150. |
2 | Includes all shares deferred under the Deferred Compensation Plan No. 2 for Directors which are scheduled to be released upon the end of their service as a director of the board. |
26 | | 2018 PROXY STATEMENT |
BENEFICIAL OWNERSHIP
|
3 | Beneficial ownership excludes unvested RSUs that will not vest within 60 days of February 26, 2018. The number of unvested RSUs held is: Dr. Wunram, 32,544; Mr. Chapman, 38,056; Mr. Leiken, 28,994; Dr. Näher, 21,443; Mr. Heyden, 21,443; and Mr. Schmid, 108,945. |
4 | Includes shares held in his/her name under the 401(k) Savings Plan over which he/she has voting power. |
5 | The amounts included in this beneficial ownership table are based on amounts held by Messrs. Mattes and Heidloff on their respective separation dates from the Company. |
Section 16(a) Beneficial Ownership Reporting Compliance
2018 PROXY STATEMENT | | 27 |
APPOINTMENT OF OUR INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
BOARD RECOMMENDATION
✓
|
FOR Proposal 2
|
The following table shows the aggregate fees billed to us for the annual audit and the review of the interim financial statements and other services provided by KPMG LLP for fiscal 2017 and 2016.
2017
|
2016
|
|||||||
Audit Fees1
|
$
|
7,792,000
|
|
$
|
7,490,000
|
| ||
Audit-Related Fees
|
|
|
|
|
|
| ||
Tax Fees2
|
$
|
1,045,000
|
|
$
|
344,000
|
| ||
All Other Fees3
|
$
|
1,024,000
|
|
$
|
718,000
|
| ||
Total
|
$
|
9,861,000
|
|
$
|
8,552,000
|
|
1 | Audit Fees consist of fees billed for professional services rendered for the audit of our annual financial statements and the review of the interim financial statements included in quarterly reports and services that are normally provided by KPMG LLP in connection with statutory and regulatory filings. |
2 | Tax Fees consist of fees billed for professional services rendered for tax compliance, tax advice and tax planning, both domestic and international. These services include assistance regarding federal, state and international tax compliance, acquisitions and international tax planning. |
3 | All Other Fees consist of fees billed for those services not captured in the audit, audit-related and tax categories. These fees include services provided by KPMG LLP in connection with the Companys revenue recognition standard readiness efforts. |
POLICY ON AUDIT COMMITTEE PRE-APPROVAL OF AUDIT AND PERMISSIBLE NON-AUDIT SERVICES OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Consistent with SEC policies regarding auditor independence, the Audit Committee has responsibility for appointing, setting compensation and overseeing the work of our independent registered public accounting firm. In recognition of this responsibility, the Audit Committee has established a policy to pre-approve all audit and non-audit services provided by the independent registered public accounting firm.
28 | | 2018 PROXY STATEMENT |
PROPOSAL 2: RATIFICATION OF APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for and any pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget. The Audit Committee has delegated pre-approval authority to Patrick W. Allender, Chair of the Audit Committee, when expedition of services is necessary, provided that Mr. Allender must report any decisions to pre-approve to the full Audit Committee at its next scheduled meeting. All of the fees included under the categories Audit-Related Fees, Tax Fees and All Other Fees above were pre-approved by the Audit Committee. None of these fees were approved by the Audit Committee after services were rendered pursuant to the de minimis exception established by the SEC.
The Board recommends a vote FOR the approval of this Proposal 2.
2018 PROXY STATEMENT | | 29 |
PROPOSAL 4: APPROVAL OF AMENDMENTS TO THE DIEBOLD NIXDORF, INCORPORATED 2017 EQUITY AND PERFORMANCE INCENTIVE PLAN
|
Outstanding full-value awards assuming that the outstanding awards achieve maximum performance under the 1991 Plan and 2017 Plan
|
6,001,492 shares or 7.90% of our outstanding shares
| |
Outstanding stock options under the 1991 Plan and 2017 Plan
|
2,642,526 shares or 3.48% of our outstanding shares
| |
Weighted average exercise price of outstanding options under the 1991 Plan and 2017 Plan
|
$27.30
| |
Weighted average remaining term of outstanding options under the 1991 Plan and 2017 Plan
|
8 years
| |
Total shares subject to outstanding awards under the 1991 Plan and 2017 Plan
|
8,644,018 shares or 11.38% of our outstanding shares
| |
Total shares available for future awards under the 1991 Plan and 2017 Plan
|
2,278,584
| |
Current overhang percentage based on total number of shares subject to outstanding awards under the 1991 Plan and 2017 Plan
|
14.38%
| |
Additional shares requested under amendment to the 2017 Plan
|
1,150,000
| |
Potential dilution of 1,150,000 additional shares as a percentage of outstanding shares
|
1.51%
| |
Total potential fully-diluted overhang under the 1991 Plan and the 2017 Plan, as amended pursuant to this proposal
|
12,072,602 shares or 15.9%.
|
2018 PROXY STATEMENT | | 33 |
PROPOSAL 4: APPROVAL OF AMENDMENTS TO THE DIEBOLD NIXDORF, INCORPORATED 2017 EQUITY AND PERFORMANCE INCENTIVE PLAN
|
2018 PROXY STATEMENT | | 35 |
PROPOSAL 4: APPROVAL OF AMENDMENTS TO THE DIEBOLD NIXDORF, INCORPORATED 2017 EQUITY AND PERFORMANCE INCENTIVE PLAN
|
36 | | 2018 PROXY STATEMENT |
PROPOSAL 4: APPROVAL OF AMENDMENTS TO THE DIEBOLD NIXDORF, INCORPORATED 2017 EQUITY AND PERFORMANCE INCENTIVE PLAN
|
2018 PROXY STATEMENT | | 37 |
PROPOSAL 4: APPROVAL OF AMENDMENTS TO THE DIEBOLD NIXDORF, INCORPORATED 2017 EQUITY AND PERFORMANCE INCENTIVE PLAN
|
The following table sets forth with respect to each named executive officer listed in the Summary Compensation Table on page 63 and each group listed below (i) the number of common shares issuable pursuant to performance units granted under the 2017 Plan, (ii) the number of common shares issuable pursuant to stock options granted under the 2017 Plan and (iii) the number of common shares issuable pursuant to RSUs awarded under the 2017 Plan, in each case since the 2017 Plans inception on April 26, 2017 through February 26, 2018 (without regard to whether any grants were subsequently forfeited, terminated or canceled). It does not include any grants made during this same period under any other compensation plans.
NAME AND POSITION
|
ESTIMATED POSSIBLE PAYOUTS UNDER EQUITY INCENTIVE PLAN AWARDS1 |
ALL OTHER STOCK AWARDS: NUMBER OF SHARES OF STOCK OR UNITS2 (#)
|
ALL OTHER OPTION AWARDS: NUMBER OF SECURITIES UNDERLYING OPTIONS3 (#)
|
EXERCISE OR BASE PRICE OF OPTION AWARDS ($/SH)
| ||||||||||||||||||||||||||
THRESHOLD (#)
|
TARGET (#)
|
MAX. (#)
|
||||||||||||||||||||||||||||
Dr. Juergen Wunram
Senior Vice President and Chief Operating Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
45,953
|
|
|
18.75
|
| ||||||||||||
|
|
|
|
|
|
|
|
|
|
26,717
|
|
|
|
|
|
|
| |||||||||||||
|
19,084
|
|
|
38,167
|
|
|
76,334
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Christopher A. Chapman Senior Vice President and Chief Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
39,572
|
|
|
18.75
|
| ||||||||||||
|
|
|
|
|
|
|
|
|
|
23,007
|
|
|
|
|
|
|
| |||||||||||||
|
16,434
|
|
|
32,867
|
|
|
65,734
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Jonathan B. Leiken Senior Vice President, Chief Legal Officer and Secretary |
|
|
|
|
|
|
|
|
|
|
|
|
|
24,517
|
|
|
18.75
|
| ||||||||||||
|
|
|
|
|
|
|
|
|
|
14,254
|
|
|
|
|
|
|
| |||||||||||||
|
10,182
|
|
|
20,363
|
|
|
40,726
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Dr. Ulrich Näher Senior Vice President, Systems |
|
|
|
|
|
|
|
|
|
|
|
|
|
30,278
|
|
|
18.75
|
| ||||||||||||
|
|
|
|
|
|
|
|
|
|
17,603
|
|
|
|
|
|
|
| |||||||||||||
|
12,574
|
|
|
25,147
|
|
|
50,294
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Olaf Heyden Senior Vice President, Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
30,278
|
|
|
18.75
|
| ||||||||||||
|
|
|
|
|
|
|
|
|
|
17,603
|
|
|
|
|
|
|
| |||||||||||||
|
12,574
|
|
|
25,147
|
|
|
50,294
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
All current executive officers as a group |
|
|
|
|
|
|
|
|
|
|
193,825
|
|
|
18.75
|
| |||||||||||||||
|
|
|
|
|
|
|
|
|
|
112,688
|
|
|
|
|
|
|
| |||||||||||||
|
80,492
|
|
|
160,983
|
|
|
321,966
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
All current non-employee directors as a group
|
|
|
|
|
|
|
|
|
|
|
56,804
|
|
|
|
|
|
|
| ||||||||||||
All employees, excluding current executive officers, as a group
|
|
|
|
|
|
|
|
|
|
|
|
|
|
153,920
|
|
|
18.75
|
| ||||||||||||
|
|
|
|
|
|
|
|
|
|
966,160
|
|
|
|
|
|
|
| |||||||||||||
|
237,583
|
|
|
475,165
|
|
|
950,330
|
|
|
|
|
|
|
|
|
|
|
1 | These columns present information about performance-based shares awarded during 2017 and 2018 pursuant to the 2017 Plan. The payout of these performance-based shares will be determined based on the achievement of specific metrics calculated over a three-year performance period. |
2 | This column presents information about RSUs awards during 2017 and 2018 pursuant to the 2017 Plan. |
3 | All stock option grants in this column are new and were not granted in connection with an option re-pricing transaction, and the terms of the stock options have not been materially modified. |
40 | | 2018 PROXY STATEMENT |
PROPOSAL 4: APPROVAL OF AMENDMENTS TO THE DIEBOLD NIXDORF, INCORPORATED 2017 EQUITY AND PERFORMANCE INCENTIVE PLAN
|
EQUITY COMPENSATION PLAN INFORMATION
The following table reflects information as of December 31, 2017 and pertains to our 1991 Plan and our current 2017 Plan:
PLAN CATEGORY
|
NUMBER OF SECURITIES TO BE ISSUED UPON EXERCISE OF OUTSTANDING OPTIONS, WARRANTS AND RIGHTS (A)
|
WEIGHTED-AVERAGE EXERCISE PRICE OF OUTSTANDING OPTIONS, WARRANTS AND
|
NUMBER OF SECURITIES REMAINING AVAILABLE FOR UNDER EQUITY PLANS (EXCLUDING SECURITIES REFLECTED
|
|||||||||
Equity compensation plans approved by security holders
|
||||||||||||
Stock options
|
|
2,294,781
|
|
|
$29.68
|
|
|
N/A
|
| |||
Restricted stock units
|
|
1,278,959
|
|
|
N/A
|
|
|
N/A
|
| |||
Performance shares
|
|
2,500,734
|
|
|
N/A
|
|
|
N/A
|
| |||
Non-employee director deferred shares
|
|
125,800
|
|
|
N/A
|
|
|
N/A
|
| |||
Deferred compensation
|
|
815
|
|
|
N/A
|
|
|
N/A
|
| |||
Total
|
|
6,201,089
|
|
|
$29.68
|
|
|
4,800,000
|
|
In column (b), the weighted-average exercise price is only applicable to options. In column (c), the number of securities remaining available for future issuance for stock options, restricted stock units, performance shares and non-employee director deferred shares is approved in total and not individually.
VOTE REQUIRED TO APPROVE THE AMENDMENTS TO THE 2017 PLAN
A favorable vote of the majority of votes cast on the matter is necessary for approval of the amendments to the 2017 Plan. Abstentions are considered votes cast on the proposal, and therefore will have the effect of a vote against the proposal. Broker non-votes will not be counted for determining whether the proposal is passed. If the amendments to the 2017 Plan are not approved by shareholders, the 2017 Plan will continue in effect under its current terms, and we will not have sufficient shares available to issue further grants of our common shares in future years beyond the remaining shares available for grants.
The Board recommends a vote FOR the approval of the amendments to the Diebold Nixdorf, Incorporated 2017 Equity and Performance Incentive Plan.
2018 PROXY STATEMENT | | 41 |
EXECUTIVE COMPENSATION MATTERS
COMPENSATION DISCUSSION AND ANALYSIS
NAME | TITLE | |
Dr. Juergen Wunram*
|
Senior Vice President and Chief Operating Officer
| |
Christopher A. Chapman*
|
Senior Vice President and Chief Financial Officer
| |
Andreas W. Mattes
|
Former President and Chief Executive Officer
| |
Jonathan B. Leiken
|
Senior Vice President, Chief Legal Officer and Secretary
| |
Dr. Ulrich Näher
|
Senior Vice President, Systems
| |
Olaf Heyden
|
Senior Vice President, Services
| |
Eckard Heidloff
|
Former President
|
* | Dr. Wunram and Mr. Chapman served as Interim Co-Presidents and Co-CEOs until February 21, 2018. |
42 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
44 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
EXECUTIVE COMPENSATION BEST PRACTICES
We maintain best practice executive compensation governance standards. Some of our following guidelines and policies are described in more detail below under Other Compensation Policies or elsewhere in this Compensation Discussion and Analysis:
WHAT WE DO
|
WHAT WE DONT DO/DONT ALLOW
| |||||
|
Set stock ownership guidelines for executives and directors.
|
|
No hedging or pledging of our stock by executives or directors.
| |||
|
Prescribe an annual limit on equity compensation for our directors.
|
|
No dividends paid on unearned performance-based shares.
| |||
|
Review tally sheets for executives.
|
|
No change-in-control severance multiple in excess of two times salary and target cash bonus.
| |||
|
Disclose performance goals for incentive payments.
|
|
No excise tax gross-ups upon a change in control.
| |||
|
Set maximum payout caps on our annual and long-term incentives.
|
|
No re-pricing or cash buyout of underwater stock options.
| |||
|
Pay for performance with 87% of our Chief Executive Officers target total pay opportunity being performance-based at risk compensation.
|
|
No enhanced retirement formulas.
| |||
|
Provide a minimum vesting period of at least one year for at least 95% of our equity awards.
|
|
No market timing with granting of equity awards.
| |||
|
Cap performance share payments if three-year shareholder return is negative, regardless of our ranking.
|
|||||
|
Limit perquisites and other benefits, and do not include income tax gross-ups (except for relocation expenses).
|
|||||
|
Hire an independent consultant reporting directly to the Committee.
|
|||||
|
Through the Committees independent consultant, engage in an ongoing assessment of our compensation practices against the market, our competition, and other applicable metrics.
|
|||||
|
Incorporate general cash severance and change-in-control provisions that are consistent with market practice, including double-trigger requirements for certain change-in-control protection.
|
|||||
|
Perform an annual compensation risk assessment.
|
|||||
|
Enforce strict insider trading policies, incentive plan clawback policies, and black-out periods for executives and directors.
|
2018 PROXY STATEMENT | | 45 |
EXECUTIVE COMPENSATION MATTERS
|
Our executive pay program is specifically designed to:
| Focus on performance metrics that align executives with the creation relative of long-term shareholder value through performance-based compensation, including the direct utilization of relative total shareholder return, or rTSR; |
| Use metrics that are balanced and support our multi-year integration and transformation programs called DN2020; |
| Encourage decision-making in alignment with our business strategies, with goal-setting based on a philosophy of continuous improvement, commitment to becoming a top tier performer and supporting our longer-term business transformation strategy; |
| Reflect industry standards, offer globally competitive program design and pay opportunities, and balance our need for talent with our need to maintain reasonable compensation costs; and |
| Attract, motivate, and retain executive talent willing to commit to building long-term shareholder value. |
Our 2017 executive compensation structure consists of three primary components: base salary, annual cash bonus, and long-term equity incentives. Within the long-term incentive (LTI) component, we utilize a mix of programs for senior leadership. In 2017, as discussed later in this Proxy Statement, we made one-time performance-based synergy grants to incentivize accelerated cost savings following the Wincor Nixdorf transaction. We also provided legacy Wincor Nixdorf employees, including those who are NEOs, with a one-time offer to receive performance-based cash incentive awards contingent upon cancellation of their outstanding Wincor Nixdorf stock options. Without the employees agreement to cancel the outstanding Wincor Nixdorf stock options, they would remain in place and be payable based on the Wincor Nixdorf stock price until the stock options expire or lapse. These grants do not represent new value, but rather an exchange of value of the Wincor Nixdorf option grants for new grants under our annual cash bonus plan to align incentives of the newly combined business. These awards are described in more detail below under Long-Term IncentivesPerformance-Based Cash Incentive Awards. Apart from these unique one-time grants, our target compensation structure for senior leadership is as follows:
As provided in more detail below, we generally target total compensation opportunity at or near the size-adjusted 50th percentile of our compensation peer group (for more detail on our peer group, see Role of Peer Companies and Competitive Market Data below). The NEOs may be above or below the 50th percentile based on their experience, performance, potential, and impact on shareholder value. Our compensation structure will continue to evolve in support of our strategic plan, DN2020.
46 | | 2018 PROXY STATEMENT |
Total Compensation Opportunity Base Salary Annual Cash Bonus Long-Term Equity Incentives 50% Performance-Based Shares 30% Stock Options 20% Restricted Stock Units
EXECUTIVE COMPENSATION MATTERS
|
The following table summarizes key elements of our 2017 executive compensation program:
ELEMENT |
PRIMARY PURPOSE |
KEY CHARACTERISTICS | ||
Base Salary |
To compensate the executive fairly and competitively
|
Fixed compensation component. | ||
Annual Cash Bonus |
To motivate and reward organizational and individual achievement of annual strategic financial and individual objectives.
Our plan is intended to appropriately motivate the behaviors and performance results needed to accomplish our strategic transformation. |
Variable compensation component. The 2017 primary performance components are:
Corporate Goals (80%) Corporate non-GAAP Operating Profit (50%) Corporate Free Cash Flow (30%)
Individual Business Goals (20%) Key Initiatives
Performance Gate: A minimum level of corporate non-GAAP Operating Profit performance is required to earn any bonus.
| ||
Long-Term Equity Incentives (LTI) |
To align executives and shareholders interests, to reinforce long-term value creation, and to provide a balanced portfolio of long-term incentive opportunity.
|
Variable compensation component. Reviewed and granted annually. | ||
Performance-Based Shares |
To motivate the appropriate behaviors to provide superior TSR and strong operational performance over the long term. |
Cumulative three-year TSR relative to S&P 400 Mid-Cap Index companies.
For Mr. Mattes, 50% based on the above TSR and 50% based on synergy metrics explained below. | ||
Stock Options |
To motivate the appropriate behaviors to increase shareholder value above the exercise price. | Stock price growth above the exercise price. Subject to three-year ratable vesting. | ||
Restricted Stock Units (RSUs) |
To motivate the appropriate behaviors to increase shareholder value and promote a base-level of executive retention. |
Stock price growth. Subject to three-year ratable vesting. | ||
Performance-Based Synergy Grants |
To incentivize the accelerated achievement of cost reductions and scale efficiencies made possible by our business combination with Wincor Nixdorf. |
One-time variable compensation based on level of achievement of synergy savings, including realized cost reductions, elimination of cost and scale efficiencies; implemented in response to comments received during 2016 shareholder outreach campaign. Our CEO was excluded from this one-time grant.
| ||
Performance-Based Cash Incentive Awards |
To align the legacy Wincor Nixdorf employees with achieving our company-wide goals. |
One-time variable compensation component based on our stock price; grant was contingent on cancellation of Wincor Nixdorf outstanding options; represents an exchange of existing value to align management incentives for the newly combined business.
| ||
Health/Welfare Plan and Retirement Benefits |
To provide competitive benefits promoting employee health and productivity and support financial security. |
Fixed compensation component. | ||
Limited Perquisites and Other Benefits |
To provide limited business-related benefits, where appropriate.
|
Fixed compensation component. | ||
Change-in-Control Protection |
To retain executives and provide management continuity in event of actual or threatened change-in-control and to bridge future employment if terminated following a change-in-control of the Company.
|
Fixed compensation component; only paid in the event the executives employment is terminated following a change-in-control of the Company. | ||
Severance Protection |
To bridge future employment if terminated other than for cause. |
Fixed compensation component; only paid in the event the executives employment is terminated other than for cause. |
2018 PROXY STATEMENT | | 47 |
EXECUTIVE COMPENSATION MATTERS
|
2017 NEO COMPENSATION HIGHLIGHTSTARGET COMPENSATION STRUCTURE
PAY COMPONENT |
SUMMARY | |
Target Total Compensation Opportunity |
Based on a review of individual performance and competitive market data, the Committee approved the following annual total compensation structure for 2017. Each element is discussed in detail in 2017 Compensation Elements. The mix of pay elements is consistent with similar roles at our peer companies.
Dr. Wunram: Increased base salary from 500,000 to 535,000 and increased long-term incentive opportunity from 100% of salary to 200% of salary in order to align the compensation with the competitive US market for the newly combined business and to maintain internal equity for management of the combined business. No change to target bonus.
Mr. Chapman: Increased base salary from $500,000 to $575,000 to move total compensation opportunity closer to 50th percentile. No change in target bonus or long-term incentive opportunity.
Mr. Mattes: No change in base salary or target bonus (as a percent of salary). Long-term incentive opportunity was increased from 450% of salary to 500% of salary to enhance long-term orientation and maintain a 50th percentile target total compensation opportunity.
Mr. Leiken: Increased base salary from $440,000 to $475,000 and increased long-term incentive opportunity from 100% of salary to 150% of salary in order to align the compensation with the competitive US market for the newly combined business and to maintain internal equity for management of the combined business. No change to target bonus.
Dr. Näher: Increased base salary from 430,000 to 470,000 and increased long-term incentive opportunity from 100% of salary to 150% of salary in order to align the compensation with the competitive US market for the newly combined business and to maintain internal equity for management of the combined business. No change to target bonus.
Mr. Heyden: Increased base salary from 430,000 to 470,000 and increased long-term incentive opportunity from 100% of salary to 150% of salary in order to align the compensation with the competitive US market for the newly combined business and to maintain internal equity for management of the combined business. No change to target bonus.
Our 2017 long-term incentive value mix was 50% performance-based shares, 30% stock options, and 20% RSUs. |
In summary, the NEOs had the following total compensation structure for 2017:
NAME
|
SALARY
|
TARGET BONUS (% OF SALARY)
|
TARGET LTI (% OF SALARY)
| ||||||||||||
Dr. Juergen Wunram
|
|
535,000
|
|
|
100
|
%
|
|
200
|
%
| ||||||
Christopher A. Chapman
|
$
|
575,000
|
|
|
100
|
%
|
|
200
|
%
| ||||||
Andreas W. Mattes
|
$
|
937,500
|
|
|
140
|
%
|
|
500
|
%
| ||||||
Jonathan B. Leiken
|
$
|
475,000
|
|
|
100
|
%
|
|
150
|
%
| ||||||
Dr. Ulrich Näher
|
|
470,000
|
|
|
100
|
%
|
|
150
|
%
| ||||||
Olaf Heyden
|
|
470,000
|
|
|
100
|
%
|
|
150
|
%
| ||||||
Eckard Heidloff
|
|
700,000
|
|
|
100
|
%
|
|
100
|
%
|
48 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
2017 NEO COMPENSATION HIGHLIGHTSACTUAL EARNED COMPENSATION
The below table represents the Committees view of the compensation actually earned and paid to the NEOs in 2017. Due to their departures during the fiscal year 2017, we are not presenting this information with respect to Messrs. Heidloff and Mattes.
EARNED VS. TARGETED COMPENSATION2017*
| |||||||||||||||||||||||||
NAME
|
ANNUAL SALARY
|
BONUS
|
LONG TERM INCENTIVE
|
TOTAL EARNED COMPENSATION
|
% OF TARGET COMPENSATION RECEIVED
| ||||||||||||||||||||
Dr. Juergen Wunram**
|
|
535,000
|
|
|
214,000
|
|
$
|
53,891
|
|
$
|
887,251
|
|
|
39
|
%
| ||||||||||
Christopher A. Chapman
|
$
|
575,000
|
|
$
|
230,000
|
|
$
|
327,155
|
|
$
|
1,132,155
|
|
|
49
|
%
| ||||||||||
Jonathan B. Leiken
|
$
|
475,000
|
|
$
|
190,000
|
|
$
|
271,489
|
|
$
|
936,489
|
|
|
56
|
%
| ||||||||||
Dr. Ulrich Näher**
|
|
470,000
|
|
|
188,000
|
|
$
|
35,502
|
|
$
|
767,612
|
|
|
44
|
%
| ||||||||||
Olaf Heyden**
|
|
470,000
|
|
|
188,000
|
|
$
|
35,502
|
|
$
|
767,612
|
|
|
44
|
%
|
* | This chart compares earned compensation in 2017 vs. the intended target at grant date. It includes earned and targeted values for 2017 base salary, 2017 annual bonus, and long-term incentives with scheduled vesting in 2017. |
** | Total Earned Compensation calculated using the exchange rate for Euros to U.S. dollars in effect on the grant date of 1.07048 for the bonus and the average exchange rate for 2017 of 1.12949 for the base salary. |
2018 PROXY STATEMENT | | 49 |
LTI Target 68% Salary 13% Target Bonus 19% LTI Target 44% Salary 28% Target Bonus 28% Fixed 13% At Risk 87% Fixed 28% At Risk 72%
EXECUTIVE COMPENSATION MATTERS
|
The following incentive compensation payouts for 2017 performance were approved, each discussed further in 2017 Compensation Elements below:
PAY COMPONENT
|
COMMENTS
|
|||||||||
Annual Cash Bonus |
Based on the Committees assessment of the Annual Cash Bonus Plan goals, including both financial and individual performance (against personalized Key Initiatives), the Committee approved the following cash bonus payments:
| |||||||||
NAME
|
EARNED BONUS
|
% OF TARGET
|
||||||||
Dr. Juergen Wunram
|
214,000
|
40%
|
||||||||
Christopher A. Chapman
|
$230,000
|
40%
|
||||||||
Jonathan B. Leiken
|
$190,000
|
40%
|
||||||||
Dr. Ulrich Näher
|
188,000
|
40%
|
||||||||
Olaf Heyden
|
188,000
|
40%
|
Financial targets were approved by the Committee in the first quarter of 2017.
At the February 2018 Committee meeting, the Committee approved the following:
Financial targets: Below threshold achievement for the non-GAAP operating profit and free cash flow
Individual business initiatives: Achievement at maximum. The Committees final performance assessment is discussed in more detail in the Annual Cash Bonus Plan section of 2017 Compensation Elements below.
|
LTI Completed Performance Periods Performance-Based Shares |
At the February 2018 Committee meeting, the Committee approved the following for the completed 2015-2017 performance share grant:
Payout of 40.7% of target, based on achieving $859.5 million of three-year cumulative non-GAAP adjusted EBITDA, or 81.4% of the target. Our three-year TSR ranking was below the 30th percentile threshold requirement against the S&P 400 Midcap Index companies and so there was no payout on that portion of the award. |
50 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
2018 PROXY STATEMENT | | 51 |
EXECUTIVE COMPENSATION MATTERS
|
In February 2017, the Committee reviewed competitive pay data prepared by Aon Hewitt to assist with 2017 compensation decisions. During the fall of 2016, the Committee approved the following peer companies:
Alliance Data Systems Corp.
|
Harris Corp.
|
Netapp Inc.
| ||
Benchmark Electronics Inc.
|
Juniper Networks, Inc.
|
Pitney-Bowes Inc.
| ||
Computer Sciences
|
Lexmark International Inc.
|
Unisys Corp.
| ||
Convergys Corp.
|
Logitech International SA
|
Western Union Company (The)
| ||
DST Systems
|
Motorola Solutions, Inc.
|
Zebra Technologies Corp.
| ||
Global Payments Inc.
|
NCR Corp.
|
Note: Compensation market values were stress tested to determine the impact, if any, of companies with larger market capitalization. The impact was immaterial.
52 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
For 2017, the Committee reviewed competitive market data and individual performance assessments for the NEOs and approved the following values at the February 2017 Committee meeting:
NAME
|
2016 SALARY
|
2017 SALARY
|
||||||
Dr. Juergen Wunram
|
|
500,000
|
|
|
535,000
|
| ||
Christopher A. Chapman
|
$
|
500,000
|
|
$
|
575,000
|
| ||
Andreas W. Mattes
|
$
|
937,500
|
|
$
|
937,500
|
| ||
Jonathan B. Leiken
|
$
|
440,000
|
|
$
|
475,000
|
| ||
Dr. Ulrich Näher
|
|
430,000
|
|
|
470,000
|
| ||
Olaf Heyden
|
|
430,000
|
|
|
470,000
|
| ||
Eckard Heidloff
|
|
700,000
|
|
|
700,000
|
|
The rationale for approved 2017 compensation actions is summarized in the table 2017 NEO Compensation HighlightsTarget Compensation Structure above.
For 2017, the Committee reviewed competitive market data and individual performance assessments for the following NEOs and approved the following target bonus levels in February 2017:
NAME
|
TARGET INCENTIVE (% OF
|
THRESHOLD INCENTIVE
|
TARGET INCENTIVE
|
MAXIMUM INCENTIVE
|
TARGET INCENTIVE AS A % OF TARGET
| ||||||||||||||||||||
Dr. Juergen Wunram
|
|
100
|
%
|
|
214,000
|
|
|
535,000
|
|
|
1,070,000
|
|
|
25
|
%
| ||||||||||
Christopher A. Chapman
|
|
100
|
%
|
$
|
230,000
|
|
$
|
575,000
|
|
$
|
1,150,000
|
|
|
25
|
%
| ||||||||||
Andreas W. Mattes
|
|
140
|
%
|
$
|
562,500
|
|
$
|
1,312,500
|
|
$
|
2,625,000
|
|
|
19
|
%
| ||||||||||
Jonathan B. Leiken
|
|
100
|
%
|
$
|
190,000
|
|
$
|
475,000
|
|
$
|
950,000
|
|
|
29
|
%
| ||||||||||
Dr. Ulrich Näher
|
|
100
|
%
|
|
188,000
|
|
|
470,000
|
|
|
940,000
|
|
|
29
|
%
| ||||||||||
Olaf Heyden
|
|
100
|
%
|
|
188,000
|
|
|
470,000
|
|
|
940,000
|
|
|
29
|
%
| ||||||||||
Eckard Heidloff
|
|
100
|
%
|
|
280,000
|
|
|
700,000
|
|
|
1,400,000
|
|
|
33
|
%
|
2018 PROXY STATEMENT | | 53 |
EXECUTIVE COMPENSATION MATTERS
|
Financial performance metrics: For 2017, the Committee approved Corporate non-GAAP Operating Profit (OP) and Corporate Free Cash Flow excluding certain transaction-related expenses (FCF) as the financial performance metrics and Key Business Initiatives specific to each NEO as the individual performance metrics. The Committee also approved a minimum performance level requirement for OP of $200M, below which no bonuses would be paid, regardless of the performance level attained for FCF, Corporate OP or individual Key Business Initiatives. Neither non-GAAP OP nor FCF was achieved at or above threshold, and so there was no payment for this portion of the award.
ANNUAL CASH BONUS PLAN FOR NEOs
| |||||||||||||||||||||||||||||||||||
PERFORMANCE MEASURE
|
ORGANIZATIONAL LEVEL
|
WEIGHTING
|
THRESHOLD1 (40% PAYOUT)
|
TARGET1 (100% PAYOUT)
|
MAX1 (200% PAYOUT)
|
ACTUAL ACHIEVED
|
PAYOUT AS
| ||||||||||||||||||||||||||||
OP
|
|
Corporate
|
|
|
50
|
%
|
|
$285M
|
|
|
$355M
|
|
|
$425M
|
|
|
$224M
|
|
|
0
|
%
| ||||||||||||||
FCF
|
|
Corporate
|
|
|
30
|
%
|
|
$ 80M
|
|
|
$100M
|
|
|
$120M
|
|
|
$(32M)
|
|
|
0
|
%
| ||||||||||||||
Key Business Initiatives
|
|
Individual
|
|
|
20
|
%
|
|
varies
|
|
|
varies
|
|
|
varies
|
|
|
varies
|
|
|
varies
|
|
1 | Payment opportunities are extrapolated between threshold, target, and maximum performance0% payout below threshold. Dollars are shown in millions. |
Key Business Initiative performance metrics: For 2017, the Committee approved Key Business Initiatives specific to each NEO. Similar to the Committees assessment of financial performance, the Committees assessment of Key Business Initiative performance generally excludes non-recurring/extraordinary items.
NAME
|
KEY BUSINESS INITIATIVE CATEGORIES (20% WEIGHTING)1
| |
Dr. Juergen Wunram |
Deliver on specific financial commitments
Business integration
Management integration related to retail and AEVI segments | |
Christopher A. Chapman |
Deliver on specific financial commitments
Capital allocation strategies
Information technology initiatives
Working capital optimization | |
Jonathan B. Leiken |
Ethics and compliance enhancements
Successful completion of specific strategic projects
Successful fulfillment of specific legal requirements | |
Olaf Heyden |
Deliver on specific financial commitments
Achievement of financial goals related to services line of business | |
Dr. Ulrich Näher |
Deliver on specific financial commitments
Achievement of financial goals related to systems line of business
Successful management of operations and research and development integration
Deliver effective leadership across systems line of business and regional matrix |
1 | We did not include Mr. Mattes Key Business Initiatives because his employment and separation agreements governed the terms for his 2017 annual cash bonus payment. Please refer to Payments and Benefits in Connection with Mr. Mattes Separation for that discussion. |
54 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
The Committee reviewed Key Business Initiative performance assessments prepared for each of the NEOs.
Each NEO listed below performed well above their stated objectives for the year. Key Business Initiatives varied by NEO, but the Boards over-arching objective for the newly combined management team was the successful integration of global personnel and business strategies. After thorough review of individual performance achievement and our global scorecard for the combined entity for the year, the Committee approved maximum payouts for this portion of the Annual Cash Bonus Plan.
KEY BUSINESS INITIATIVE PERFORMANCE
NAME
|
AMOUNT EARNED
| ||||
Dr. Juergen Wunram
|
|
214,000
|
| ||
Christopher A. Chapman
|
$
|
230,000
|
| ||
Jonathan B. Leiken
|
$
|
190,000
|
| ||
Dr. Ulrich Näher
|
|
188,000
|
| ||
Olaf Heyden
|
|
188,000
|
|
2017 Actual Bonuses Earned: Based on the Committees assessment of financial and individual performance according to the tables above, the following summarizes actual bonuses earned:
NAME
|
2017 ACTUAL BONUS
|
2017 TARGET BONUS
|
ACTUAL AS % OF TARGET
| ||||||||||||
Dr. Juergen Wunram
|
|
214,000
|
|
|
535,000
|
|
|
40
|
%
| ||||||
Christopher A. Chapman
|
$
|
230,000
|
|
$
|
575,000
|
|
|
40
|
%
| ||||||
Jonathan B. Leiken
|
$
|
190,000
|
|
$
|
475,000
|
|
|
40
|
%
| ||||||
Dr. Ulrich Näher
|
|
188,000
|
|
|
470,000
|
|
|
40
|
%
| ||||||
Olaf Heyden
|
|
188,000
|
|
|
470,000
|
|
|
40
|
%
|
2018 PROXY STATEMENT | | 55 |
EXECUTIVE COMPENSATION MATTERS
|
The following table summarizes 2017 targeted LTI values for our NEOs in accordance with our regular annual LTI grant program excluding the synergy grants and the performance-based cash incentive awards.
NAME
|
SALARY
|
TARGET LTI (% OF SALARY)
|
APPROXIMATE TARGET LTI VALUE1
| ||||||||||||
Dr. Juergen Wunram
|
|
535,000
|
|
|
200
|
%
|
|
1,070,000
|
| ||||||
Christopher A. Chapman
|
$
|
575,000
|
|
|
200
|
%
|
$
|
1,150,000
|
| ||||||
Andreas W. Mattes
|
$
|
937,500
|
|
|
500
|
%
|
$
|
4,687,500
|
| ||||||
Jonathan B. Leiken
|
$
|
475,000
|
|
|
150
|
%
|
$
|
712,500
|
| ||||||
Dr. Ulrich Näher
|
|
470,000
|
|
|
150
|
%
|
|
705,000
|
| ||||||
Olaf Heyden
|
|
470,000
|
|
|
150
|
%
|
|
705,000
|
| ||||||
Eckard Heidloff
|
|
700,000
|
|
|
100
|
%
|
|
700,000
|
|
1 | The target award values shown here generally vary from the award values listed in the Grant of Plan-Based Awards Table (GPBAT). To mitigate the potential impact of stock price swings on our equity grants, we use the 20-day average closing stock price immediately preceding the grant date to determine the grant size, rather than the closing stock price on the actual grant date as shown in the GPBAT and used for accounting purposes. The GPBAT uses the Monte Carlo valuation (the method used to determine accounting expense) which often generates a value higher than target on the grant date, which we believe is inappropriate for purposes of setting compensation opportunity. |
56 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
The Synergy Grants are intended to incentivize the accelerated achievement of cost reductions and scale efficiencies made possible by our business combination with Wincor Nixdorf. Performance under the awards is based on the achievement of certain levels of synergy savings, defined as the realized cost reductions resulting from streamlined processes, the elimination of redundant/overlapping cost (including reductions in our workforce and facilities/overhead), and scale efficiencies gained due to the business combination. The Committee approved the following metrics and payout schedule for the Synergy Grants based on synergy savings for the three-year performance period ending December 31, 2019.
THRESHOLD
|
TARGET
|
MAXIMUM
| |||||||||||||
Synergy Savings
|
$
|
160M
|
|
$
|
200M
|
|
$
|
240M
|
|
The table below outlines the Synergy Grant values at target for the NEOs, which are derived from a percentage of salary ranging between 70% and 100%:
NAME
|
TARGET INCENTIVE
| ||||
Dr. Juergen Wunram
|
$
|
581,237
|
| ||
Christopher A. Chapman
|
$
|
437,676
|
| ||
Jonathan B. Leiken
|
$
|
337,448
|
| ||
Dr. Ulrich Näher
|
$
|
357,451
|
| ||
Olaf Heyden
|
$
|
357,451
|
|
2018 PROXY STATEMENT | | 57 |
EXECUTIVE COMPENSATION MATTERS
|
at threshold, and a maximum at approximately 155% of our stock price. If the threshold price is not met, there will be no payment of the award. Any cash amount earned between threshold, target, and maximum will be calculated on a straight-line basis. The measurement of the share price for purposes of the DN Performance Awards will be based upon the average share price of our stock for the 20-day trading period prior to the end of the applicable performance period.
See below for the threshold, target, and cash incentive that each participating NEO may earn under the DN Performance Awards at target.
NAME
|
OPTIONS CANCELLED
|
PERFORMANCE PERIOD ENDING
|
CONVERTED TARGET VALUE
| ||||||||||||
Dr. Juergen Wunram |
|
62,403
|
|
|
3/26/2018
|
|
$
|
549,146
|
| ||||||
|
79,852
|
|
|
3/25/2019
|
|
$
|
2,035,427
|
| |||||||
|
66,016
|
|
|
3/30/2020
|
|
$
|
1,126,893
|
| |||||||
Olaf Heyden |
|
43,682
|
|
|
3/26/2018
|
|
$
|
384,402
|
| ||||||
|
55,897
|
|
|
3/25/2019
|
|
$
|
1,424,815
|
| |||||||
|
56,774
|
|
|
3/30/2020
|
|
$
|
969,132
|
| |||||||
Dr. Ulrich Näher |
|
55,897
|
|
|
3/25/2019
|
|
$
|
1,424,815
|
| ||||||
|
56,774
|
|
|
3/30/2020
|
|
$
|
969,132
|
| |||||||
Eckard Heidloff1 |
|
87,364
|
|
|
3/26/2018
|
|
$
|
768,803
|
| ||||||
|
111,793
|
|
|
3/25/2019
|
|
$
|
2,849,604
|
| |||||||
|
92,422
|
|
|
3/30/2020
|
|
$
|
1,577,644
|
|
1 | Mr. Heidloff had the right, pursuant to his separation agreement, to cancel his Wincor Nixdorf options in connection with our offer to the other executives. |
The following table summarizes the performance measures for each DN Performance Award:
PERFORMANCE PERIOD ENDING
|
THRESHOLD
|
TARGET
|
MAXIMUM
| ||||||||||||
3/26/2018
|
|
$17.37
|
|
|
$26.18
|
|
|
$40.76
|
| ||||||
3/25/2019
|
|
$ 0.68
|
|
|
$26.18
|
|
|
$40.76
|
| ||||||
3/30/2020
|
|
$ 9.10
|
|
|
$26.18
|
|
|
$40.76
|
|
58 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
The participation status of our NEOs in the SERPs is summarized below:
NAMED EXECUTIVE OFFICER
|
401(K) RESTORATION SERP
|
PENSION RESTORATION SERP
| ||
Dr. Juergen Wunram
|
|
| ||
Christopher A. Chapman
|
|
X
| ||
Andreas W. Mattes
|
X
|
| ||
Jonathan B. Leiken
|
X
|
| ||
Dr. Ulrich Näher
|
|
| ||
Olaf Heyden
|
|
| ||
Eckard Heidloff
|
|
|
2018 PROXY STATEMENT | | 59 |
EXECUTIVE COMPENSATION MATTERS
|
60 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
62 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
The table below summarizes the total compensation earned by each of our NEOs for the fiscal years ended December 31, 2017, 2016 and 2015, as applicable. The amounts shown include compensation for services in all capacities that were provided to us.
2017 SUMMARY COMPENSATION TABLE
NAME AND PRINCIPAL POSITION |
YEAR |
SALARY1 ($) |
BONUS ($) |
STOCK AWARDS2 ($) |
OPTION AWARDS3 ($) |
NON-EQUITY INCENTIVE PLAN COMPENSATION4 ($) |
CHANGE IN PENSION AND NON- QUALIFIED DEFERRED COMPENSATION EARNINGS5 ($) |
ALL OTHER COMPENSATION6 ($) |
TOTAL ($) | ||||||||||||||||||||||||||||||||||||
Dr. Juergen Wunram |
|
2017 |
|
|
598,446 |
|
|
|
|
|
1,583,750 |
|
|
342,116 |
|
|
267,089 |
|
|
105,588 |
|
|
154,204 |
|
|
3,051,193 |
| ||||||||||||||||||
Senior Vice President and |
2016 | 230,553 | | | | 925,357 | | 116,133 | 1,272,043 | ||||||||||||||||||||||||||||||||||||
Chief Operating Officer*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||
Christopher A. Chapman |
|
2017 |
|
|
574,178 |
|
|
|
|
|
1,710,187 |
|
|
343,487 |
|
|
230,000 |
|
|
80,875 |
|
|
39,491 |
|
|
2,978,218 |
| ||||||||||||||||||
Senior Vice President and |
2016 | 500,000 | | 700,757 | 300,000 | 331,500 | 47,575 | 39,797 | 1,919,629 | ||||||||||||||||||||||||||||||||||||
Chief Financial Officer*
|
|
2015
|
|
|
402,658
|
|
|
|
|
|
499,284
|
|
|
263,740
|
|
|
180,000
|
|
|
|
|
|
34,432
|
|
|
1,380,114
|
| ||||||||||||||||||
Andreas W. Mattes |
|
2017 |
|
|
963,382 |
|
|
|
|
|
4,217,980 |
|
|
908,000 |
|
|
249,555 |
|
|
|
|
|
5,904,919 |
|
|
12,243,836 |
| ||||||||||||||||||
Former Chief Executive |
2016 | 937,500 | | 3,179,794 | 1,074,000 | 585,000 | | 190,458 | 5,966,752 | ||||||||||||||||||||||||||||||||||||
Officer and President
|
|
2015
|
|
|
928,418
|
|
|
|
|
|
6,271,703
|
|
|
1,408,680
|
|
|
459,375
|
|
|
|
|
|
322,998
|
|
|
9,391,174
|
| ||||||||||||||||||
Jonathan B. Leiken |
|
2017 |
|
|
472,849 |
|
|
|
|
|
1,227,054 |
|
|
212,813 |
|
|
190,000 |
|
|
|
|
|
36,818 |
|
|
2,139,534 |
| ||||||||||||||||||
Senior Vice President, |
2016 | 440,000 | | 538,448 | 132,000 | 324,720 | | 37,210 | 1,472,378 | ||||||||||||||||||||||||||||||||||||
Chief Legal Officer and Secretary
|
2015 | 400,000 | | 285,304 | 150,708 | 160,000 | | 26,392 | 1,022,404 | ||||||||||||||||||||||||||||||||||||
Dr. Ulrich Näher |
|
2017 |
|
|
460,411 |
|
|
|
|
|
1,017,990 |
|
|
225,411 |
|
|
234,639 |
|
|
68,392 |
|
|
104,992 |
|
|
2,111,835 |
| ||||||||||||||||||
Senior Vice President, Systems |
| | | | | | | | | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||
Olaf Heyden |
|
2017 |
|
|
460,411 |
|
|
|
|
|
1,017,990 |
|
|
225,411 |
|
|
234,639 |
|
|
71,992 |
|
|
129,237 |
|
|
2,139,680 |
| ||||||||||||||||||
Senior Vice President, Services |
| | | | | | | | | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||
Eckard Heidloff |
|
2017 |
|
|
194,953 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
207,576 |
|
|
5,443,527 |
|
|
5,846,056 |
| ||||||||||||||||||
Former President |
2016 | 322,775 | | | | 1,295,500 | | 142,385 | 1,760,660 | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* | Dr. Wunram and Mr. Chapman were serving as our Interim Co-Presidents and Co-CEOs at fiscal year-end. |
1 | Earned salary amounts reported for Drs. Wunram and Näher and Messrs. Heyden and Heidloff are included in the table in U.S. dollars, but these executives receive their salaries in Euros. To convert their Euro salary amounts to U.S. dollars for the table, we used the average Euro to U.S. dollar foreign currency exchange rate for 2017 of 1.12949. The annual salary rates for Drs. Wunram and Näher and Mr. Heyden during calendar year 2017 under their service agreements were 535,000, 470,000, and 470,000 respectively. These increases from their 2016 salary rates took effect in April 2017. See Service Agreements with Drs. Wunram and Näher and Mr. Heyden below for additional information. For Dr. Wunram and Mr. Chapman, this amount also reflects the prorated portion of their CEO-stipend for December 2017. For Mr. Mattes, this amount reflects salary earned for 2017 and cash paid to Mr. Mattes in lieu of vacation in connection with his departure. |
2 | 2017 amounts in this column represent the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718 (ASC 718), for RSUs and performance-based LTI shares awarded to the NEOs in 2017. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. The grant date values in the table and this footnote do not necessarily correspond to the actual value that will be realized by the NEOs. The grant date fair values for the RSUs are determined using the closing price of our common shares on the grant date. The grant date fair values included in the table for the annual performance-based LTI shares are calculated based on the probable outcome of the relevant performance conditions as of the grant date, which we calculate using a Monte Carlo simulation model. For Mr. Mattes, the grant date fair value for his performance-based LTI shares and for his performance-based deferred shares is calculated (i) using a Monte Carlo simulation model with respect to 50% of the award based on relative TSR and (ii) the closing price of our common shares on the grant date and assuming target level achievement of the synergy savings goal for the remaining 50% of the award. For the performance-share based Synergy Grant, the grant date fair value is calculated using the closing price of our common shares on the grant date and assuming target level achievement of the synergy savings goal. See the 2017 Grants of Plan-Based Awards Table below for the threshold, target and maximum numbers of shares that each NEO may earn under these performance-based LTI awards and Footnote 5 to that table for additional information on assumptions used in calculating the grant date valuations. The ASC 718 grant date fair values for each NEOs |
2018 PROXY STATEMENT | | 63 |
EXECUTIVE COMPENSATION MATTERS
|
2017 performance-based LTI awards assuming the achievement of the maximum level of performance would be: for Dr. Wunram, $2,702,532; for Mr. Chapman, $2,421,543; for Mr. Mattes, $5,529,836; for Mr. Leiken, $1,632,859; for Dr. Näher, $1,729,602 and for Mr. Heyden, $1,729,602. |
The specific terms of each of these awards are discussed in more detail in Compensation Discussion and Analysis above. |
Mr. Heidloff did not receive any stock awards in 2017. |
3 | This column represents the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718, for options awarded to the NEOs in 2017. For more information regarding 2017 grants, see the 2017 Grants of Plan-Based Awards Table below. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. The assumptions used in calculating the fair value of these stock options can be found under Note 6 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2017. The specific terms of the stock options are discussed in more detail above under Compensation Discussion and Analysis. These amounts reflect the grant date fair value for these awards, and do not necessarily correspond to the actual value that will be realized by the NEOs. |
Mr. Heidloff did not receive any option awards in 2017. |
4 | This column reflects amounts earned by Messrs. Chapman, Leiken, and Heyden and Drs. Wunram and Näher under our Annual Cash Bonus Plan for the 2017 fiscal year, but that were not actually paid out until March 2018. For Mr. Mattes, this amount reflects the amount earned under our Annual Cash Bonus Plan for the 2017 fiscal year, pro-rated for his time of employment. For Drs. Wunram and Näher and Mr. Heyden, this amount was converted from Euros to U.S. Dollars using the exchange rate on February 1, 2018 of 1.24808, which was the date the Compensation Committee approved the performance achieved and payout of the award. |
5 | The amount shown for Messrs. Chapman, Heyden and Heidloff and Drs. Wunram and Näher is the difference (to the extent positive) between the actuarial present value of pension benefits as of December 31, 2017 and the actuarial present value of pension benefits as of December 31, 2016 under the pension plans in which they participate. For Mr. Chapman, the actuarial present value as of December 31, 2017 is calculated based on a 3.71% discount rate and the RP-2014 mortality tables, including the MP-2017 generational projection scales. The actuarial present value of pension benefits as of December 31, 2016 is based on a 4.24% discount rate and the RP-2014 Mortality Table including the MP-2016 generational projection scales. The values were determined assuming the probability is nil that Mr. Chapman will terminate, retire, die or become disabled before his normal retirement date (unless already known). The increase in pension value is attributable to the decrease in the discount rate and the decrease in the discounting period by one year due to the aging of Mr. Chapman. For Messrs. Heyden and Heidloff and Drs. Wunram and Näher, the actuarial present value is calculated based on a 1.40% discount rate and assuming that the probability is nil of termination, death, disability or retirement before normal retirement age. The increase in pension values are attributable to the additional accrued benefits and the decrease in the discount rate. |
There was no above-market or preferential interest earned by any NEO in 2017 on non-qualified deferred compensation. |
6 | The amounts reported as All Other Compensation for 2017 are outlined in the table below, with respect to: (a) for Messrs. Mattes, Chapman and Leiken, amounts contributed for the executive by us under our 401(k) plan and any non-qualified defined contribution plan, including taxes attributable to such non-qualified defined contribution plan, for which the executive is a participant and for Drs. Wunram and Näher and Messrs. Heidloff and Heyden, annual pension benefit contributions for the executives under the Wincor Pension Plan and the executives service agreement, which are reflected in the tables in U.S. dollars and were converted from their Euro amounts to U.S. dollars using the exchange rate of 1.19986 at December 31, 2017 for Drs. Wunram and Näher and Mr. Heyden and the exchange rate of 1.06977 at March 31, 2017 for Mr. Heidloff, (b) financial planning services/tax preparation assistance, (c) dividend equivalents paid on unvested RSUs, and (d) other. The amount in column (d) reflects, as applicable: expenses related to the Companys sales awards recognition program (Mr. Mattes $8,337; Mr. Chapman $6,462; and Mr. Heidloff $9,315 (converted to U.S. dollars using the exchange rate of 1.06977 at March 31, 2017)); the value of life insurance and AD&D premiums paid for Mr. Mattes $1,620; Mr. Chapman $1,357; and Mr. Leiken $1,136; the value of subsidy pension insurance premiums paid for Dr. Wunram $8,047; Mr. Heyden $8,047; Dr. Näher $8,047; and Mr. Heidloff $2,012; the value of supplemental executive disability insurance premiums paid for Mr. Mattes $5,508 and Mr. Chapman $2,783; accident liability insurance premiums for Dr. Wunram $617; Mr. Heyden, $657; and Dr. Näher $617; and the approximate value of an annual physical exam provided to the NEOs (Mr. Mattes $1,612 and Mr. Chapman $2,225). For Drs. Wunram and Näher and Messrs. Heidloff and Heyden column (d) also reflects the value of health insurance premiums paid for the NEOs (Dr. Wunram $5,056; Mr. Heyden $4,652; Dr. Näher $4,500; and Mr. Heidloff $679) and the amounts provided to the NEOs related to use of a company car (Dr. Wunram $15,538; Mr. Heyden $17,184; Dr. Näher $24,871; and Mr. Heidloff $3,667). Unless otherwise noted, for Drs. Wunram and Näher and Messrs. Heyden and Heidloff, amounts included in column (d) in the table below are in U.S. dollars, but were received in Euros, and we used the average Euro to U.S. dollar foreign currency exchange rate for 2017 of 1.12949 for these amounts. |
64 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
The amounts reported as All Other Compensation for 2017 for Mr. Heidloff and Mr. Mattes, with respect to column (d) also include the following payments and benefits accrued in relation to their termination. For Mr. Heidloff: cash severance $4,611,575, annual cash bonus, granted pro-rata and based on 100% achievement of all relevant targets, $374,420 and accelerated long-term equity $374,420. These amounts were paid to Mr. Heidloff in Euros under the terms of his separation agreement and were converted to U.S. dollars using the exchange rate of 1.06977 at March 31, 2017. Mr. Heidloff may be entitled to certain other future payments under his DN Performance Awards which have not been included in his 2017 All Other Compensation amount. Those potential payments and benefits are described in detail and quantified in the Payments and Benefits in Connection with Mr. Heidloffs Separation section under Potential Payments Upon Termination or Change in Control. For Mr. Mattes: cash severance $4,500,000; the aggregate value as of the separation date of the RSUs that vested upon his separation $931,860; and the value of the portion of his 2015-2017 performance-based share award earned, $343,615. Mr. Mattes is also entitled to certain other payments and benefits under his employment agreement and release, which may be incurred in the future that are subject to the non-competition, non-solicitation, and confidentiality provisions under his release and which have not been included in his 2017 All Other Compensation amount. Those potential payments and benefits are described in detail and quantified in the Payments and Benefits in Connection with Mr. Mattes Separation section under Potential Payments Upon Termination or Change in Control. |
ALL OTHER COMPENSATION | ||||||||||||||||||||
NAMED EXECUTIVE OFFICER |
(A) |
(B) |
(C) |
(D) | ||||||||||||||||
Dr. Juergen Wunram
|
|
119,986
|
|
|
1,464
|
|
|
3,496
|
|
|
29,258
|
| ||||||||
Christopher A. Chapman
|
|
9,955
|
|
|
5,410
|
|
|
11,299
|
|
|
12,827
|
| ||||||||
Andreas W. Mattes
|
|
54,542
|
|
|
16,000
|
|
|
41,825
|
|
|
5,792,552
|
| ||||||||
Jonathan B. Leiken
|
|
14,942
|
|
|
10,000
|
|
|
10,740
|
|
|
1,136
|
| ||||||||
Dr. Ulrich Näher
|
|
59,993
|
|
|
4,660
|
|
|
2,304
|
|
|
38,035
|
| ||||||||
Olaf Heyden
|
|
59,993
|
|
|
36,400
|
|
|
2,304
|
|
|
30,540
|
| ||||||||
Eckard Heidloff
|
|
67,439
|
|
|
|
|
|
|
|
|
5,376,088
|
|
2018 PROXY STATEMENT | | 65 |
EXECUTIVE COMPENSATION MATTERS
|
2017 GRANTS OF PLAN-BASED AWARDS TABLE
NAME
|
ESTIMATED POSSIBLE PAYOUTS UNDER NON-EQUITY INCENTIVE PLAN AWARDS1 |
ESTIMATED FUTURE PAYOUTS UNDER EQUITY |
ALL OTHER STOCK AWARDS: NUMBER OF SHARES OF STOCK OR UNITS3 (#)
|
ALL OTHER OPTION AWARDS: NUMBER OF SECURITIES UNDERLYING OPTIONS4 (#)
|
EXERCISE OR BASE PRICE OF OPTION AWARDS ($/SH)
|
GRANT FAIR VALUE STOCK OPTION AWARDS5 ($)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
GRANT DATE
|
THRESHOLD ($)
|
TARGET ($)
|
MAX. ($)
|
THRESHOLD (#)
|
TARGET (#)
|
MAX. (#)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dr. Juergen Wunram |
|
2/8/2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75,356 |
|
|
26.60 |
|
|
342,116 |
| |||||||||||||||||||||||||||
2/8/2017 | | | | | | | 8,740 | | | 232,484 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 10,923 | 21,851 | 43,702 | | | | 770,029 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 10,923 | 21,851 | 43,702 | | | | 581,237 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 229,083 | 572,707 | 1,145,414 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
5/1/2017 | 624 | 549,146 | 1,459,606 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
5/1/2017 | 799 | 2,035,427 | 3,200,468 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
5/1/2017
|
|
|
660
|
|
|
1,126,893
|
|
|
2,090,067
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||||||||||
Christopher A. Chapman |
|
2/8/2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75,658 |
|
|
26.60 |
|
|
343,487 |
| |||||||||||||||||||||||||||
2/8/2017 | | | | | | | 8,775 | | | 233,415 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 10,969 | 21,938 | 43,876 | | | | 773,095 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 8,227 | 16,454 | 32,908 | | | | 437,676 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 230,000 | 575,000 | 1,150,000 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
266,000
|
| ||||||||||||||||||||||||||||
Andreas W. Mattes |
|
2/8/2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000 |
|
|
26.60 |
|
|
908,000 |
| |||||||||||||||||||||||||||
2/8/2017 | | | | | | | 54,626 | | | 1,453,052 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 28,195 | 56,390 | 112,780 | | | | 1,743,579 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 16,516 | 33,032 | 66,064 | | | | 1,021,349 | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
562,500
|
|
|
1,312,500
|
|
|
2,625,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||||||||||
Jonathan B. Leiken |
|
2/8/2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46,875 |
|
|
26.60 |
|
|
212,813 |
| |||||||||||||||||||||||||||
2/8/2017 | | | | | | | 5,437 | | | 144,624 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 6,796 | 13,592 | 27,184 | | | | 478,982 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 6,343 | 12,686 | 25,372 | | | | 335,852 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 190,000 | 475,000 | 950,000 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
266,000
|
| ||||||||||||||||||||||||||||
Dr. Ulrich Näher |
|
2/8/2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49,650 |
|
|
26.60 |
|
|
225,411 |
| |||||||||||||||||||||||||||
2/8/2017 | | | | | | | 5,759 | | | 153,189 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 7,199 | 14,397 | 28,794 | | | | 507,350 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 6,719 | 13,438 | 26,876 | | | | 357,451 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 201,250 | 503,126 | 1,006,251 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
5/1/2017 | 558 | 1,424,815 | 2,240,352 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
5/1/2017
|
|
|
567
|
|
|
969,132
|
|
|
1,797,465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||||||||||
Olaf Heyden |
|
2/8/2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49,650 |
|
|
26.60 |
|
|
225,411 |
| |||||||||||||||||||||||||||
2/8/2017 | | | | | | | 5,759 | | | 153,189 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 7,199 | 14,397 | 28,794 | | | | 507,350 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/8/2017 | | | | 6,719 | 13,438 | 26,876 | | | | 357,451 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 201,250 | 503,126 | 1,006,252 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
5/1/2017 | 437 | 384,402 | 1,021,722 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
5/1/2017 | 558 | 1,424,815 | 2,240,352 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
5/1/2017
|
|
|
567
|
|
|
969,132
|
|
|
1,797,465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||||||||||
Eckard Heidloff |
|
5/1/2017 |
|
|
874 |
|
|
768,803 |
|
|
2,043,444 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||||||||
5/1/2017 | 1,118 | 2,849,604 | 4,480,663 | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
5/1/2017
|
|
|
924
|
|
|
1,577,644
|
|
|
2,926,081
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 | These columns present information about the potential payouts under our Annual Cash Bonus Plan for fiscal year 2017. The actual amount paid in March 2018 for each NEO is reflected above in the 2017 Summary Compensation Table under the Non-Equity Incentive Plan Compensation column. For Drs. Wunram and Näher and Mr. Heyden, these amounts were converted from Euros to U.S. dollars using the exchange rate on February 8, 2018 of 1.07048, which was the grant date. Mr. Heidloff did not receive an award under our Annual Cash Bonus Plan for fiscal year 2017. For a more detailed description of the related performance measures for all of these cash incentive awards see above under Compensation Discussion and Analysis. |
66 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
For Drs. Wunram and Näher and Messrs. Heidloff and Heyden, this column also presents the potential payouts under their DN Performance Awards for the performance periods ending in March 2018, 2019, and 2020, respectively. For a more detailed description of the related performance measures for the DN Performance Awards see above under Compensation Discussion and Analysis. |
2 | These columns present information about performance-based LTI shares awarded during 2017 pursuant to the 1991 Plan. The payout of the performance-based LTI shares will be determined based on the achievement of specific relative TSR goals calculated over the three-year period beginning on January 1, 2017 and ending on December 31, 2019. For Mr. Mattes, the payout of his annual performance based LTI shares will be determined based on the achievement of specific relative TSR and synergy savings goals. The maximum award amount for the performance-based LTI awards is 200% of the target amount, which will be earned only if we achieve maximum performance pursuant to the grants specific performance measures, and no amount is payable unless the threshold performance is met. For Mr. Mattes, this column also presents information about his performance-based deferred shares awarded during 2017 pursuant to the 1991 Plan. The performance requirements for Mr. Mattes performance-based deferred shares are identical to those of his performance-based LTI shares. For a more detailed description of these awards and the related performance measures, see the related descriptions in the Compensation Discussion and Analysis. |
Except for Messrs. Mattes and Heidloff, these columns also present information about performance-based shares awarded under the Synergy Grant. The payout for the Synergy Grant will be determined based on the achievement of specific synergy savings targets calculated over the three-year period beginning January 1, 2017 and ending December 31, 2019. For a more detail description of this award and the related performance measures, see the related description in the Compensation Discussion and Analysis. |
3 | This column presents information about RSUs awarded during 2017 pursuant to the 1991 Plan. For a more detailed description of the RSUs, see above under Compensation Discussion and Analysis. |
4 | All stock option grants in this table were new and not granted in connection with an option re-pricing transaction, and the terms of the stock options were not materially modified in 2017. For a more detailed description of the stock options, see above under Compensation Discussion and Analysis. |
5 | For the annual performance-based LTI shares, and the relative TSR portion of Mr. Mattes annual performance-based LTI shares and performance-based deferred shares, the grant date fair value of $35.24 per share as of the grant date was calculated using a Monte Carlo simulation model that considers the likelihood of our TSR ending at various percentile levels and expected stock price at those levels and which reflects the probable outcome of the performance conditions at target as of the grant date, excluding the effect of estimated forfeitures, in accordance with FASB ASC Topic 718. The assumptions used in calculating the fair value of the performance-based LTI shares were as follows: (a) an expected performance period of three years; (b) a risk-free interest rate of 1.37%, which is an estimated interest rate for a zero-coupon U.S. government bond with a term commensurate with the remaining term of the performance period as of the grant date (2.89 years), calculated by linear interpolation of the interest rates on the grant date for zero coupon U.S. government bonds with maturities of 2.50 and 3.0 years; (c) historical volatilities of the Company and peer group, calculated using the adjusted daily stock prices for the 2.89 year period prior to the grant date; and (d) a dividend yield for the Company and any of the peer group companies in the period from January 1, 2017 to February 8, 2017. |
For the Synergy Grant and the synergy savings portion of Mr. Mattes performance-based LTI shares and performance-based deferred shares, the grant date fair value is calculated based upon the closing price of our common shares on the grant date and assuming target level of achievement of the synergy savings goal. |
For RSUs, the fair value is calculated using the closing market price of the shares on the applicable grant date ($26.60), and such value reflects the total amount that we would expect to expense in our financial statements over the awards three-year vesting period. For stock options, the fair value was calculated using the Black-Scholes value on the grant date of $4.54, calculated in accordance with FASB ASC Topic 718. The assumptions used in calculating the fair value of these stock options can be found under Note 6 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2017. |
2018 PROXY STATEMENT | | 67 |
EXECUTIVE COMPENSATION MATTERS
|
68 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
2018 PROXY STATEMENT | | 69 |
EXECUTIVE COMPENSATION MATTERS
|
OUTSTANDING EQUITY AWARDS AT 2017 FISCAL YEAR-END
The following table provides information relating to exercisable and unexercisable stock options as of December 31, 2017 for the NEOs. In addition, the following table provides information relating to grants of RSUs, deferred shares and performance-based awards to the NEOs that had not yet vested as of December 31, 2017. No stock appreciation rights were outstanding as of December 31, 2017. Mr. Heidloff did not hold any outstanding equity awards at 2017 fiscal year-end.
OPTION AWARDS1 |
STOCK AWARDS | |||||||||||||||||||||||||||||||||||||||||||||||||
NUMBER OF SECURITIES UNDERLYING UNEXERCISED OPTIONS |
EQUITY INCENTIVE PLAN AWARDS: | |||||||||||||||||||||||||||||||||||||||||||||||||
NAME
|
GRANT
|
EXERCISABLE
|
UNEXERCISABLE
|
EQUITY
|
OPTION ($)
|
OPTION
|
NUMBER
|
MARKET
|
NUMBER
|
MARKET OR
| ||||||||||||||||||||||||||||||||||||||||
Dr. Juergen |
|
2/8/2017
|
|
|
|
|
|
75,356
|
|
|
|
|
|
26.60
|
|
|
2/8/2027
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,740
|
|
|
142,899
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,923
|
|
|
178,591
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,923
|
|
|
178,591
|
| |||||||||||||||||||||
Christopher A. Chapman |
|
2/11/2009
|
|
|
1,250
|
|
|
|
|
|
|
|
|
24.79
|
|
|
2/11/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||
|
2/11/2010
|
|
|
2,500
|
|
|
|
|
|
|
|
|
27.88
|
|
|
2/11/2020
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/10/2011
|
|
|
7,000
|
|
|
|
|
|
|
|
|
32.67
|
|
|
2/10/2021
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/8/2012
|
|
|
9,500
|
|
|
|
|
|
|
|
|
34.89
|
|
|
2/8/2022
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/6/2013
|
|
|
7,540
|
|
|
|
|
|
|
|
|
29.87
|
|
|
2/6/2023
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/11/2014
|
|
|
10,166
|
|
|
|
|
|
|
|
|
34.13
|
|
|
2/11/2024
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/5/2015
|
|
|
24,963
|
|
|
12,482
|
|
|
|
|
|
32.33
|
|
|
2/5/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/3/2016
|
|
|
18,622
|
|
|
37,244
|
|
|
|
|
|
27.39
|
|
|
2/3/2026
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
75,658
|
|
|
|
|
|
26.60
|
|
|
2/8/2027
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/5/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,408
|
|
|
72,071
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/3/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,064
|
|
|
82,796
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,775
|
|
|
306,971
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/5/2015
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,486
|
|
|
73,346
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/3/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,128
|
|
|
149,243
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,969
|
|
|
179,343
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,227
|
|
|
134,511
|
| |||||||||||||||||||||
Andreas W. |
|
6/6/2013
|
|
|
98,082
|
|
|
|
|
|
|
|
|
31.92
|
|
|
6/6/2023
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||
|
2/11/2014
|
|
|
154,766
|
|
|
|
|
|
|
|
|
34.13
|
|
|
2/11/2024
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/5/2015
|
|
|
200,000
|
6
|
|
|
|
|
|
|
|
32.33
|
|
|
2/5/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/3/2016
|
|
|
200,000
|
6
|
|
|
|
|
|
|
|
27.39
|
|
|
2/3/2026
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
200,000
|
6
|
|
|
|
|
|
|
|
26.60
|
|
|
12/13/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/5/2015
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,029
|
|
|
392,874
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/3/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,970
|
|
|
424,610
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,905
|
|
|
243,697
|
|
70 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
OPTION AWARDS1 |
STOCK AWARDS | |||||||||||||||||||||||||||||||||||||||||||||||||
NUMBER OF SECURITIES UNDERLYING UNEXERCISED OPTIONS |
EQUITY INCENTIVE PLAN AWARDS: | |||||||||||||||||||||||||||||||||||||||||||||||||
NAME
|
GRANT
|
EXERCISABLE
|
UNEXERCISABLE
|
EQUITY
|
OPTION ($)
|
OPTION
|
NUMBER
|
MARKET
|
NUMBER
|
MARKET OR
| ||||||||||||||||||||||||||||||||||||||||
Jonathan B. Leiken |
|
2/5/2015
|
|
|
14,264
|
|
|
7,133
|
|
|
|
|
|
32.33
|
|
|
2/5/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||
|
2/3/2016
|
|
|
8,193
|
|
|
16,388
|
|
|
|
|
|
27.39
|
|
|
2/3/2026
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
46,875
|
|
|
|
|
|
26.60
|
|
|
2/8/2027
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/5/2015
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,519
|
|
|
41,186
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/3/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,228
|
|
|
36,428
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/11/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,667
|
|
|
109,005
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,437
|
|
|
252,395
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/5/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,564
|
|
|
41,921
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/3/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,017
|
|
|
65,678
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,796
|
|
|
111,115
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,343
|
|
|
103,708
|
| |||||||||||||||||||||
Dr. Ulrich Näher |
|
2/8/2017
|
|
|
|
|
|
49,650
|
|
|
|
|
|
26.60
|
|
|
2/8/2027
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,759
|
|
|
94,160
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,199
|
|
|
117,704
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,719
|
|
|
109,856
|
| |||||||||||||||||||||
Olaf Heyden |
|
2/8/2017
|
|
|
|
|
|
49,650
|
|
|
|
|
|
26.60
|
|
|
2/8/2027
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,759
|
|
|
94,160
|
|
|
|
|
|
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,199
|
|
|
117,704
|
| |||||||||||||||||||||
|
2/8/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,719
|
|
|
109,856
|
|
1 | For Messrs. Mattes, Chapman, and Leiken, all stock options outstanding at the 2017 fiscal year-end which were issued prior to 2013 vest ratably over a four-year period beginning on the first anniversary of the date of grant. All stock option grants outstanding at the 2017 fiscal year-end which were issued in and after 2013 vest ratably over a three-year period beginning on the first anniversary of the date of grant. |
2 | This column reflects unvested RSUs granted to the NEOs as of December 31, 2017. The RSUs included in this column vest ratably over a three-year period, except for the RSUs granted on February 5, 2015, which have a three-year cliff vest. This column also reflects the 2015-2017 performance-based LTI shares. See note 5 below. |
3 | The market value was calculated using the closing price of our common shares of $16.35 as of December 31, 2017. |
4 | This column reports the performance-based LTI shares granted to the NEOs for the 2016-2018 and 2017-2019 performance periods, as applicable. For both 2016-2018 and 2017-2019 performance periods, relative TSR was below the applicable threshold as of December 31, 2017, and we have included the awards at threshold. For Mr. Mattes 2017-2019 performance-based LTI shares, relative TSR and synergy savings were both below the applicable threshold as of December 31, 2017 and we have included the award at threshold. The 2016-2018 and 2017-2019 performance-based LTI awards are scheduled to vest and be paid in February 2019 and February 2020, respectively. |
This column also reports the performance-based Synergy Grant shares granted to the NEO for a 2017-2019 performance period. Synergy savings was below the applicable threshold as of December 31, 2017, and we have included the awards at threshold. The Synergy Grant is scheduled to vest and be paid in February 2020. |
5 | The number of shares reflected on this row represents the actual number of shares earned under the 2015-2017 performance-based LTI shares, as determined by the Compensation Committee following the end of the performance period. Market value is calculated using the closing price of our common shares on December 31, 2017. These shares vested on February 13, 2018. |
6 | The number of options reported include an aggregate amount of 400,000 options that immediately vested upon Mr. Mattes separation from the Company. Such accelerated options remain exercisable for the twenty-four month period following his termination. |
2018 PROXY STATEMENT | | 71 |
EXECUTIVE COMPENSATION MATTERS
|
2017 OPTION EXERCISES AND STOCK VESTED
OPTION AWARDS1 |
STOCK AWARDS | ||||||||||||||||||||||||
NAME |
NUMBER OF (#) |
VALUE ($) |
NUMBER OF (#) |
VALUE ($) | |||||||||||||||||||||
Dr. Juergen Wunram
|
90,999 | 3,067,863 | | | |||||||||||||||||||||
Christopher A. Chapman
|
| | 7,925 | 218,565 | |||||||||||||||||||||
Andreas W. Mattes
|
| | 163,980 | 3 | 4,139,996 | ||||||||||||||||||||
Jonathan B. Leiken
|
| | 7,914 | 222,229 | |||||||||||||||||||||
Dr. Ulrich Näher
|
| | | | |||||||||||||||||||||
Olaf Heyden
|
| | | | |||||||||||||||||||||
Eckard Heidloff
|
127,398 | 4,294,661 | | |
1 | Mr. Heidloff and Dr. Wunrams 2013 options, previously granted by Wincor Nixdorf, were cash settled. They did not receive any shares upon exercise. The value realized on exercise was 3,941,394 for Mr. Heidloff and 2,815,509 for Dr. Wunram. These amounts were converted to U.S. dollars using the Euro to U.S. dollar foreign currency exchange rate on April 30, 2017. |
2 | The value realized is calculated by multiplying the number of shares of stock by the market value of the underlying securities on the vesting date. The number of shares actually received upon vesting may be less than the number shown, due to shares being withheld for the payment of applicable taxes. The value realized for Mr. Mattes accelerated RSUs (51,770 of the reported shares) is calculated by multiplying the shares of stock by the close price on his separation date ($18.00). As settlement of Mr. Mattes RSUs was delayed until 2018 in accordance with 409(A) and his release, the value of the shares provided to Mr. Mattes on the payment dates may differ from that in the table. |
3 | This number does not include Mr. Mattes 2015-2017 performance-based shares as these shares vested in 2018. |
2017 PENSION AND RETIREMENT BENEFITS
NAME
|
PLAN NAME
|
NUMBER OF YEARS CREDITED SERVICE (#)
|
PRESENT VALUE OF ACCUMULATED BENEFIT ($)
|
PAYMENTS DURING LAST FISCAL YEAR ($)
| |||||||||||||
Dr. Juergen Wunram |
Wincor Nixdorf AG Pension Scheme
|
10.83 | 1,629,410 | 1 | | ||||||||||||
Christopher A. Chapman |
Qualified Retirement Plan
|
|
21.333
|
|
|
307,077
|
2
|
| |||||||||
Pension Restoration SERP
|
|
21.333
|
|
|
145,751
|
2
|
|
|
| ||||||||
Andreas W. Mattes
|
| | | | |||||||||||||
Jonathan B. Leiken
|
| | | | |||||||||||||
Dr. Ulrich Näher |
Wincor Nixdorf AG Pension Scheme
|
3.00 | 203,976 | 1 | | ||||||||||||
Olaf Heyden |
Wincor Nixdorf AG Pension Scheme
|
4.67 | 319,163 | 1 | | ||||||||||||
Eckard Heidloff |
Wincor Nixdorf AG Pension Scheme
|
34.25 | 1,992,967 | 1 | |
1 | For Drs. Wunram and Näher and Messrs. Heyden and Heidloff, the present value of accumulated benefit is based on projected benefits earned through age 60, respectively, assuming a discount rate of 1.4%, and that there is no probability of termination, retirement, death, or disability before normal retirement age. The present value of accumulated benefit for Drs. Wunram and Näher and Messrs. Heyden and Heidloff is 1,358,000, 170,000, 266,000 and 1,661,000, respectively. The dollar amounts reflected in the table were calculated using the Euro to U.S. dollar foreign currency exchange rate on December 31, 2017. |
2 | For Mr. Chapman, the values are determined based on a 3.71% discount rate and the RP-2014 mortality tables, including the MP-2017 generational projection scales and are calculated assuming that the probability is nil that a NEO terminates, dies, retires or becomes disabled before normal retirement date. |
72 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
2018 PROXY STATEMENT | | 73 |
EXECUTIVE COMPENSATION MATTERS
|
2017 NON-QUALIFIED DEFERRED COMPENSATION
NAME
|
EXECUTIVE CONTRIBUTIONS IN 20171 ($)
|
REGISTRANT CONTRIBUTIONS IN 20172 ($)
|
AGGREGATE EARNINGS IN 20173 ($)
|
AGGREGATE WITHDRAWALS/ DISTRIBUTIONS ($)
|
AGGREGATE BALANCE 20174 ($)
| ||||||||||||||||||||
Dr. Juergen Wunram
|
| | | | | ||||||||||||||||||||
Christopher A. Chapman
|
| | | | | ||||||||||||||||||||
Andreas W. Mattes
|
73,636 | 44,181 | 108,636 | | 780,611 | ||||||||||||||||||||
Jonathan B. Leiken
|
10,207 | 6,124 | 11,788 | | 69,445 | ||||||||||||||||||||
Dr. Ulrich Näher
|
| | | | | ||||||||||||||||||||
Olaf Heyden
|
| | | | | ||||||||||||||||||||
Eckard Heidloff
|
| | | | |
1 | These amounts are included in the Salary column of the 2017 Summary Compensation Table. |
2 | These amounts are included in the All Other Compensation column of the 2017 Summary Compensation Table and include amounts contributed in 2017 for the 2017 plan year under the 401(k) Restoration SERP. |
3 | These amounts represent aggregate earnings on executive and registrant contributions. These amounts are not reflected in the 2017 Summary Compensation Table, as they are not considered preferential or above-market earnings on deferred compensation. |
4 | This column reflects the balance of all contributions and the aggregate earnings (or losses) on such contributions. No portion of this amount is reflected in the All Other Compensation column or the Salary column of the 2017 Summary Compensation Table except current-year Registrant Contributions and Executive Contributions, respectively. Of these balances, the following amounts were reported as executive and registrant contributions in summary compensation tables in prior year proxy statements: Mr. Mattes, $227,149 and Mr. Leiken, $10,193. |
NON-QUALIFIED DEFERRED COMPENSATION PLANS
74 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
MERRILL LYNCH FUNDS
NAME OF FUND
|
RATE OF RETURN
|
NAME OF FUND
|
RATE OF RETURN
| |||||||||
Federated International CL IS
|
|
28.30
|
%
|
Vanguard Target Retirement 2060
|
|
21.42
|
%
| |||||
Invesco Diversified DIV CL R5
|
|
8.53
|
%
|
Loomis Sayles Bond FD Instl
|
|
7.48
|
%
| |||||
Janus Triton Fund CL I
|
|
27.07
|
%
|
Loomis Sayles Small Cap Value Instl
|
|
10.02
|
%
| |||||
John Hancock Disciplined Value Mid Cap Instl
|
|
15.64
|
%
|
Vanguard Institutional Index
|
|
21.79
|
%
| |||||
Vanguard Target Retirement 2015
|
|
11.50
|
%
|
Vanguard Total Bond Market Instl
|
|
3.57
|
%
| |||||
Vanguard Target Retirement 2020
|
|
14.13
|
%
|
Vanguard Mid-Cap Index Fund
|
|
19.12
|
%
| |||||
Vanguard Target Retirement 2025
|
|
15.94
|
%
|
Vanguard Primecap FD-ADM CL
|
|
29.61
|
%
| |||||
Vanguard Target Retirement 2030
|
|
17.57
|
%
|
Vanguard Target Income Retirement
|
|
8.54
|
%
| |||||
Vanguard Target Retirement 2035
|
|
19.14
|
%
|
T Rowe Price Blue Chip Growth
|
|
36.55
|
%
| |||||
Vanguard Target Retirement 2040
|
|
20.73
|
%
|
Oppenheimer Developing Markets Fund Y
|
|
35.10
|
%
| |||||
Vanguard Target Retirement 2045
|
|
21.47
|
%
|
American Balanced Fund R5
|
|
15.77
|
%
| |||||
Vanguard Target Retirement 2050
|
|
21.47
|
%
|
BlackRock Liquidity FD T Instl
|
|
0.75
|
%
| |||||
Vanguard Target Retirement 2055
|
|
21.47
|
%
|
GERMAN PENSION BENEFITS
POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL
2018 PROXY STATEMENT | | 75 |
EXECUTIVE COMPENSATION MATTERS
|
76 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
PAYMENTS MADE UPON TERMINATIONMESSRS. CHAPMAN AND LEIKEN
2018 PROXY STATEMENT | | 77 |
EXECUTIVE COMPENSATION MATTERS
|
78 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
2018 PROXY STATEMENT | | 79 |
EXECUTIVE COMPENSATION MATTERS
|
POTENTIAL TERMINATION PAYMENTS UNDER SERVICE AGREEMENTSDRS. WUNRAM AND NÄHER AND MR. HEYDEN
80 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
2018 PROXY STATEMENT | | 81 |
EXECUTIVE COMPENSATION MATTERS
|
POST-TERMINATION PAYMENTS TABLES
NAME
|
VOLUNTARY W/O GOOD ($)
|
INVOLUNTARY ($)
|
INVOLUNTARY W/O CAUSE OR VOLUNTARY REASON ($)
|
RETIREMENT ($)
|
DEATH ($)
|
DISABILITY ($)
|
CHANGE IN CONTROL W/ TERMINATION ($)
| ||||||||||||||||||||||||||||
Christopher A. Chapman
|
|||||||||||||||||||||||||||||||||||
Salary/Bonus
|
|
|
|
|
|
|
|
2,530,000
|
|
|
|
|
|
230,000
|
|
|
230,000
|
|
|
2,530,000
|
| ||||||||||||||
Stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||
Performance shares1
|
|
|
|
|
|
|
|
585,400
|
|
|
|
|
|
585,450
|
|
|
585,450
|
|
|
1,097,526
|
| ||||||||||||||
RSUs
|
|
|
|
|
|
|
|
213,860
|
|
|
|
|
|
461,838
|
|
|
461,838
|
|
|
461,838
|
| ||||||||||||||
Pension Plans and SERP Benefits2
|
|
452,829
|
|
|
307,077
|
|
|
452,829
|
|
|
|
|
|
121,078
|
|
|
1,079,662
|
|
|
452,829
|
| ||||||||||||||
Other Benefits3
|
|
|
|
|
|
|
|
72,085
|
|
|
|
|
|
|
|
|
|
|
|
28,542
|
| ||||||||||||||
Total:
|
|
452,829
|
|
|
307,077
|
|
|
3,854,174
|
|
|
|
|
|
1,398,366
|
|
|
2,356,950
|
|
|
4,570,735
|
4
| ||||||||||||||
Jonathan B. Leiken
|
|||||||||||||||||||||||||||||||||||
Salary/Bonus
|
|
|
|
|
|
|
|
1,615,000
|
|
|
|
|
|
190,000
|
|
|
190,000
|
|
|
2,090,000
|
| ||||||||||||||
Stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||
Performance shares1
|
|
|
|
|
|
|
|
333,371
|
|
|
|
|
|
333,731
|
|
|
333,731
|
|
|
663,941
|
| ||||||||||||||
RSUs
|
|
|
|
|
|
|
|
206,788
|
|
|
|
|
|
439,014
|
|
|
439,014
|
|
|
439,014
|
| ||||||||||||||
Pension Plans and SERP Benefits2
|
|
69,445
|
|
|
47,476
|
|
|
69,445
|
|
|
69,445
|
|
|
69,445
|
|
|
69,445
|
|
|
73,521
|
| ||||||||||||||
Other Benefits3
|
|
|
|
|
|
|
|
42,642
|
|
|
|
|
|
|
|
|
|
|
|
24,570
|
| ||||||||||||||
Total:
|
|
69,445
|
|
|
47,476
|
|
|
2,267,246
|
|
|
69,445
|
|
|
1,032,190
|
|
|
1,032,190
|
|
|
3,291,046
|
4
|
82 | | 2018 PROXY STATEMENT |
EXECUTIVE COMPENSATION MATTERS
|
1 | For all outstanding performance-based awards, we have assumed that the payouts of the awards will be made at target levels. In reality, the payouts may be lower or higher depending upon the actual level of performance achieved in the future. |
2 | The Pension Plans and SERP Benefits amount represents the total value to the NEO under our defined benefit and defined contribution plans, excluding the Qualified 401(k) Plan. The assumptions used to calculate the value of the Qualified Retirement Plan and Pension Restoration SERP benefits are consistent with those used to calculate the values above under 2017 Pension and Retirement Benefits. Retirement eligibility is age 50 with 70 points under the Qualified Pension and Pension Restoration SERP. For Mr. Leiken, the values include the vested balance in the 401(k) Restoration SERP. This balance is payable when the participant turns age 55 or their current age if older than 55. |
3 | Other Benefits includes, as applicable, the total value of any other contributions by us on behalf of the NEO for health and welfare benefit plans and outplacement services, which the NEO was eligible to receive as of December 31, 2017. |
4 | These payments would be subject (in whole or in part) to an excise tax imposed by Section 280G of the Code. In accordance with the NEOs change in control or employment agreement, we will reduce certain of these payments to the extent necessary so that no portion of the total payment is subject to the excise tax, but only if this results in a better net-of-tax result for the NEO. The calculations in this table do not reflect any such reduction or adjustment. |
As discussed above, Drs. Wunram and Nähers and Mr. Heydens respective service agreements govern their severance payments. These agreements do not provide change in control protection. Amounts presented in the table below assume a hypothetical termination event as of December 31, 2017 and may vary from the amounts and German law presentation in the Compensation Report included in Diebold Nixdorfs 16/17 Annual Report. All amounts were converted from Euros to U.S. dollars using the exchange rate on December 31, 2017, which was 1.19986.
NAME
|
VOLUNTARY
|
INVOLUNTARY W/CAUSE ($)
|
VOLUNTARY W/GOOD REASON ($)
|
MUTUALLY AGREED TERMINATION OR SPECIAL CIRCUMSTANCES ($)
|
RETIREMENT ($)
|
DEATH ($)
|
DISABILITY ($)
| ||||||||||||||||||||||||||||
Dr. Juergen Wunram |
|||||||||||||||||||||||||||||||||||
Severance |
| | 2,824,470 | 3,150,939 | | 577,733 | 1,219,658 | ||||||||||||||||||||||||||||
Stock options |
| | | | | | | ||||||||||||||||||||||||||||
Performance Shares1 |
| | 235,233 | 235,233 | 705,699 | 235,233 | 235,233 | ||||||||||||||||||||||||||||
RSUs |
| | 42,543 | 42,543 | 142,899 | 142,899 | 142,899 | ||||||||||||||||||||||||||||
DN Performance Awards2 |
3,711,467 | | 3,711,467 | 3,711,467 | 3,711,467 | 2,422,897 | 2,422,897 | ||||||||||||||||||||||||||||
Pension Plan Benefits3 |
1,629,410 | 1,629,410 | 1,629,410 | 1,629,410 | 1,629,410 | 1,629,410 | 1,629,410 | ||||||||||||||||||||||||||||
Other Benefits4 |
| | 41,206 | | | | | ||||||||||||||||||||||||||||
Total: |
5,340,877 | 1,629,410 | 8,484,329 | 8,769,592 | 6,189,475 | 5,008,172 | 5,650,097 | ||||||||||||||||||||||||||||
Dr. Ulrich Näher |
|||||||||||||||||||||||||||||||||||
Severance |
| | 1,917,376 | 1,917,376 | | 507,541 | 1,071,475 | ||||||||||||||||||||||||||||
Stock options |
| | | | | | | ||||||||||||||||||||||||||||
Performance Shares1 |
| | 151,701 | 151,701 | | 151,701 | 151,701 | ||||||||||||||||||||||||||||
RSUs |
| | 28,033 | 28,033 | | 94,160 | 94,160 | ||||||||||||||||||||||||||||
DN Performance Awards2 |
2,393,947 | | 2,393,947 | 2,393,947 | 2,393,947 | 1,413,108 | 1,413,108 | ||||||||||||||||||||||||||||
Pension Plan Benefits3 |
203,976 | 203,976 | 203,976 | 203,976 | 203,976 | 203,976 | 203,976 | ||||||||||||||||||||||||||||
Other Benefits4 |
| | 33,822 | 33,822 | | | | ||||||||||||||||||||||||||||
Total: |
2,597,923 | 203,976 | 4,728,855 | 4,728,855 | 2,597,923 | 2,370,486 | 2,934,420 | ||||||||||||||||||||||||||||
Olaf Heyden |
|||||||||||||||||||||||||||||||||||
Severance |
| | 1,917,376 | 1,917,376 | | 507,541 | 1,071,475 | ||||||||||||||||||||||||||||
Stock options |
| | | | | | | ||||||||||||||||||||||||||||
Performance Shares1 |
| | 151,701 | 151,701 | | 151,701 | 151,701 | ||||||||||||||||||||||||||||
RSUs |
| | 28,033 | 28,033 | | 94,160 | 94,160 | ||||||||||||||||||||||||||||
DN Performance Awards2 |
2,778,348 | | 2,778,348 | 2,778,348 | 2,778,348 | 1,775,145 | 1,775,145 | ||||||||||||||||||||||||||||
Pension Plan Benefits3 |
319,163 | 319,163 | 319,163 | 319,163 | 319,163 | 319,163 | 319,163 | ||||||||||||||||||||||||||||
Other Benefits4 |
| | 34,049 | 34,049 | | | | ||||||||||||||||||||||||||||
Total: |
3,097,511 | 319,163 | 5,228,670 | 5,228,670 | 3,097,511 | 2,847,710 | 3,411,644 |
2018 PROXY STATEMENT | | 83 |
EXECUTIVE COMPENSATION MATTERS
|
1 | For all outstanding performance-based awards, we have assumed that the payouts of the awards will be made at target levels. In reality, the payouts may be lower or higher depending upon the actual level of performance achieved in the future. |
2 | For all outstanding DN Performance Awards, we have assumed that the payouts of the awards will be made at target levels. |
3 | The pension plan benefits amount represents the total value to Drs. Wunram and Näher and Mr. Heyden under the Wincor Nixdorf AG Pension Scheme. The assumptions used to calculate the value are consistent with those described above under 2017 Pension and Retirement Benefits. |
4 | Other Benefits includes, as applicable, the total value of any other contributions by us on behalf of the NEO for health and welfare benefit plans and outplacement services, which the NEO was eligible to receive as of December 31, 2017. |
84 | | 2018 PROXY STATEMENT |
The Audit Committee is currently comprised of Patrick W. Allender, Chair, Dr. Dieter W. Düsedau, Gale S. Fitzgerald, and Robert S. Prather, Jr. Each member of the committee is independent as defined in the NYSE Listed Company Manual and SEC rules. The primary duties and responsibilities of the committee are (1) to monitor the adequacy of our financial reporting process and systems of internal controls regarding finance, accounting and legal compliance, (2) to monitor the independence and performance of our outside auditors and internal audit department, and (3) to provide an avenue of communication among the outside auditors, management, the internal audit department and the Board. The Board has adopted an Audit Committee Charter, which is available on our website at http://www.dieboldnixdorf.com.
The Audit Committee has reviewed and discussed with our management and KPMG LLP, our independent registered public accounting firm, the audited financial statements contained in our Annual Report to Shareholders for the year ended December 31, 2017. The Audit Committee has also discussed with our independent registered public accounting firm the matters required to be discussed pursuant to AS No. 1301 Communications with Audit Committees, issued by the Public Company Accounting Oversight Board (United States) (PCAOB).
The Audit Committee has received and reviewed the written disclosures and the letter from KPMG LLP required by applicable requirements of the Public Company Accounting Oversight Board regarding KPMG LLPs communications with the Audit Committee concerning independence, and has discussed with KPMG LLP its independence. The Audit Committee has also considered whether the provision of non-audit services to us by KPMG LLP is compatible with maintaining its independence.
Based on the review and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 filed with the SEC.
The foregoing report was submitted by the Audit Committee and shall not be deemed to be soliciting material or to be filed with the SEC or subject to Regulation 14A promulgated by the SEC or Section 18 of the Exchange Act.
The Audit Committee:
Patrick W. Allender, Chair
Dieter W. Düsedau
Gale S. Fitzgerald
Robert S. Prather, Jr.
2018 PROXY STATEMENT | | 85 |
APPENDIX A
DIEBOLD NIXDORF, INCORPORATED
2017 EQUITY AND PERFORMANCE INCENTIVE PLAN
AMENDED , 2018
ARTICLE I
ESTABLISHMENT AND PURPOSE
1.1 Purpose. The purpose of this Equity and Performance Incentive Plan (this Plan) is to attract and retain directors, officers and employees for Diebold Nixdorf, Incorporated (the Company) and its Subsidiaries and to provide to such persons incentives and rewards for performance.
1.2 Participation. Persons eligible to participate in this Plan include Employees and Directors. Subject to the provisions of this Plan, the Committee may from time to time select those Employees and Directors to whom Awards shall be granted and shall determine the nature and amount of those Awards. No Employee or Director shall have the right to be granted an Award.
1.3 Duration of the Plan. This Plan shall become effective on the date that it is approved by the Companys shareholders (the Effective Date) and shall remain in effect, subject to the right of the Board to terminate this Plan at any time pursuant to Section 15.1, until all Shares subject to it have been purchased or acquired. However, in no event shall any Award be granted under this Plan on or after the tenth (10th) anniversary of the Effective Date.
ARTICLE II
DEFINITIONS
As used in this Plan,
2.1 Annual Meeting means the annual meeting of shareholders of the Company.
2.2 Award means any right granted under this Plan, including an Option, a Stock Appreciation Right, a Restricted Share award, a Restricted Stock Unit award, a Performance Share or a Performance Unit award, or an Other Share-Based award.
2.3 Award Agreement means an agreement, certificate, resolution or other type or form of writing or other evidence approved by the Committee which sets forth the terms and conditions of an individual Award granted under this Plan which may, in the discretion of the Company, be transmitted electronically to the Participant. Each Award Agreement shall be subject to the terms and conditions of this Plan.
A-1 |
2.4 Board means the Board of Directors of the Company.
2.5 Business Combination has the meaning provided in Section 2.6(c) of this Plan.
2.6 Change in Control means the occurrence of any of the following:
(a) The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a Person) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of thirty percent (30%) or more of either: (A) the then-outstanding shares of common stock of the Company (the Company Common Stock) or (B) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of Directors (Voting Stock); provided, however, that for purposes of this subsection (a), the following acquisitions shall not constitute a Change in Control: (1) any acquisition directly from the Company, (2) any acquisition by the Company, (3) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Subsidiary, or (4) any acquisition by any Person pursuant to a transaction which complies with clauses (A), (B) and (C) of subsection (c) of this Section 2.6; or
(b) Individuals who, as of the date hereof, constitute the Board (as modified by this subsection (b), the Incumbent Board), cease for any reason (other than death or disability) to constitute at least a majority of the Board; provided, however, that any individual becoming a Director subsequent to the date hereof whose election, or nomination for election by the Companys shareholders, was approved by a vote of at least a majority of the Directors then comprising the Incumbent Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for Director, without objection to such nomination) shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of Directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(c) Consummation of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the assets of the Company (a Business Combination), in each case, unless, following such Business Combination, (A) all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Company Common Stock and Voting Stock immediately prior to such Business Combination beneficially own, directly or indirectly, more than fifty percent (50%) of, respectively, the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity which as a result of such transaction owns the Company or all or substantially all of the Companys assets either directly or through one or more subsidiaries) in substantially the same proportions relative to each other as their ownership, immediately prior to such Business Combination, of the Company Common Stock and Voting Stock, as the case may be, (B) no Person (excluding any entity resulting from such Business Combination or any employee benefit plan (or related trust) sponsored or maintained by the Company or such entity resulting from such Business Combination) beneficially owns, directly or indirectly, thirty percent (30%) or more of, respectively, the then-outstanding shares of common stock of the entity resulting from such Business Combination, or the combined voting power of the then-outstanding voting securities of such
A-2 |
corporation except to the extent that such ownership existed prior to the Business Combination and (C) at least a majority of the members of the board of directors of the corporation resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board providing for such Business Combination; or
(d) Approval by the shareholders of the Company of a complete liquidation or dissolution of the Company.
A Change in Control will be deemed to occur (i) with respect to a Change in Control pursuant to subsection (a) above, on the date that any Person becomes the beneficial owner of thirty percent (30%) or more of either the Company Common Stock or Voting Stock, (ii) with respect to a Change in Control pursuant to subsection (b) above, on the date the members of the Incumbent Board first cease for any reason (other than death or disability) to constitute at least a majority of the Board, (iii) with respect to a Change in Control pursuant to subsection (c) above, on the date the applicable transaction closes and (iv) with respect to a Change in Control pursuant to subsection (d) above, on the date of the shareholder approval. Notwithstanding the foregoing provisions, a Change in Control shall not be deemed to have occurred for purposes of this Plan solely because of a change in control of any Subsidiary by which the Participant may be employed.
2.7 Code means the Internal Revenue Code of 1986, as amended from time to time.
2.8 Committee has the meaning provided in Section 14.1 of this Plan.
2.9 Common Shares means shares of common stock, $1.25 par value per share, of the Company or any security into which such Common Shares may be changed by reason of any transaction or event of the type referred to in Article XI of this Plan.
2.10 Company Common Stock has the meaning provided in Section 2.6(a) of this Plan.
2.11 Date of Grant means the date on which the Committee adopts a resolution, or takes other appropriate action, expressly granting an Award to a Participant that specifies the key terms and conditions of the Award or, if a later date is set forth in such resolution, then such later date as is set forth therein.
2.12 Designated Subsidiary means a Subsidiary that is (i) not a corporation or (ii) a corporation in which at the time the Company owns or controls, directly or indirectly, less than eighty percent (80%) of the total combined voting power represented by all classes of stock issued by such corporation.
2.13 Detrimental Activity means any of the following:
(a) Engaging in any activity, as an employee, principal, agent or consultant for another entity, and in a capacity, that directly competes with the Company or any Subsidiary in any actual product, service, or business activity (or in any product, service, or business activity which was under active development while the Participant was employed by the Company if such development is being actively pursued by the Company during the one (1) year period following the termination of the Participants employment by the Company or a Subsidiary) for which the Participant has had any direct responsibility and direct involvement during the last two (2) years of his or her employment with the Company or a Subsidiary, in any territory in which the Company or a Subsidiary manufactures, sells, markets, services, or installs such product or service or engages in such business activity.
A-3 |
(b) Soliciting any Employee to terminate his or her employment with the Company or a Subsidiary.
(c) The disclosure to anyone outside of the Company or a Subsidiary, or the use in other than the Company or a Subsidiarys business, without prior written authorization from the Company, of any confidential, proprietary or trade secret information or material relating to the business of the Company and its Subsidiaries, acquired by the Participant during his or her employment with the Company or its Subsidiaries or while acting as a consultant for the Company or its Subsidiaries thereafter; provided, however, that nothing in this Plan limits a Participants ability to file a charge or complaint or to communicate, including by providing documents or other information without notice to the Company, with the Securities and Exchange Commission or any other governmental agency or commission (Government Agency) or limits a Participants right to receive an award for information provided to any Government Agency.
(d) The failure or refusal to disclose promptly and to assign to the Company upon request all right, title and interest in any invention or idea, patentable or not, made or conceived by the Participant during the Participants employment by the Company or any Subsidiary, relating in any manner to the actual or anticipated business, research or development work of the Company or any Subsidiary or the failure or refusal to do anything reasonably necessary to enable the Company or any Subsidiary to secure a patent where appropriate in the United States and in other countries.
(e) Activity that results in termination for cause, as such term is defined in the applicable Award Agreement.
2.14 Director means a director of the Company.
2.15 Disability means totally and permanently disabled as from time to time defined under the long-term disability plan of the Company or a Subsidiary applicable to the Participant, or, in the case where there is no applicable plan, permanent and total disability as defined in Section 22(e)(3) of the Code (or any successor provision); provided, however, that to the extent an amount payable under this Plan which constitutes deferred compensation subject to Section 409A of the Code would become payable upon Disability, Disability for purposes of such payment shall not be deemed to have occurred unless the disability also satisfies the requirements of treasury regulation 1.409A-3.
2.16 EBIT has the meaning provided in Section 2.24(c) of this Plan.
2.17 EBITDA has the meaning provided in Section 2.24(c) of this Plan.
2.18 Effective Date has the meaning provided in Section 1.3 of this Plan.
2.19 Employee means an employee of the Company or any of its Subsidiaries, including an employee who is an officer or a Director.
2.20 Exchange Act means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, as such law, rules and regulations may be amended from time to time.
2.21 Exercise Price means, with respect to an Option or Stock Appreciation Right, the price at which a Common Share may be purchased upon exercise thereof.
A-4 |
2.22 Fair Market Value means, as of any particular date, the closing price of a Common Share as reported for that date on the New York Stock Exchange or, if the Common Shares are not then listed on the New York Stock Exchange, on any other national securities exchange on which the Common Shares are listed, or if there are no sales on such date, on the next preceding trading day during which a sale occurred. If there is no regular public trading market for the Common Shares, then the Fair Market Value shall be the fair market value as determined in good faith by the Board.
2.23 Free Standing Rights has the meaning provided in Section 5.1 of this Plan.
2.24 Government Agency has the meaning provided in Section 2.13(c) of this Plan.
2.25 Incentive Stock Option means an Option intended to qualify as an incentive stock option under Section 422 of the Code or any successor provision.
2.26 Incumbent Board has the meaning provided in Section 2.6(b) of this Plan.
2.27 Management Goals means, for a Performance Period, the one or more goals established by the Committee, which, for any Award shall be based only upon the Management Objectives.
(a) The Committee may provide that any evaluation of Management Goals shall include or exclude any of the following items: (i) asset write-downs; (ii) litigation or claim judgments or settlements; (iii) the effect of changes in tax laws, accounting principles, regulations, or other laws or regulations affecting reported results; (iv) any reorganization and restructuring programs; (v) acquisitions or divestitures; (vi) unusual, nonrecurring or extraordinary items identified in the Companys audited financial statements, including footnotes, or in managements discussion and analysis in the Companys annual report; (vii) foreign exchange gains and losses; (viii) change in the Companys fiscal year; and (ix) any other specific unusual or nonrecurring events, or objectively determinable category thereof.
(b) If the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company, or the manner in which it conducts its business, or other events or circumstances render the Management Goals unsuitable, the Committee may in its discretion modify such Management Goals or the related minimum acceptable level of achievement, in whole or in part, as the Committee deems appropriate and equitable.
2.28 Management Objectives means the measurable performance objective or objectives selected by the Committee for purposes of establishing the Management Goal(s) for a Performance Period with respect to any Award under this Plan. The Management Objectives that will be used to establish the Management Goals shall be based on the attainment of specific levels of performance of the Company, a Subsidiary, division, business unit, operational unit, department, region or function within the Company or Subsidiary in which the Participant is employed. The Management Objectives applicable to any Award shall be limited to one or more, or a combination, of the following:
(a) Sales, including (i) net sales, (ii) unit sales volume, and (iii) aggregate product price;
(b) Share price, including (i) market price per share, and (ii) share price appreciation;
(c) Earnings, including (i) earnings per share, reflecting dilution of shares, (ii) gross or pre-tax profits, (iii) post-tax profits, (iv) operating profit, (v) earnings net of or including dividends,
A-5 |
(vi) earnings net of or including the after-tax cost of capital, (vii) earnings before (or after) interest and taxes (EBIT), (viii) earnings per share from continuing operations, diluted or basic, (ix) earnings before (or after) interest, taxes, depreciation and amortization (EBITDA), (x) pre-tax operating earnings after interest and before incentives, service fees and extraordinary or special items, (xi) operating earnings, (xii) growth in earnings or growth in earnings per share, and (xiii) total earnings;
(d) Return on equity, including (i) return on equity, (ii) return on invested capital, (iii) return or net return on assets, (iv) return on net assets, (v) return on gross sales, (vi) return on investment, (vii) return on capital, (viii) return on invested capital, (ix) return on committed capital, (x) financial return ratios, (xi) value of assets, and (xii) change in assets;
(e) Cash flow(s), including (i) operating cash flow, (ii) net cash flow, (iii) free cash flow, and (iv) cash flow on investment;
(f) Revenue, including (i) gross or net revenue, and (ii) changes in annual revenues;
(g) Margins, including (i) adjusted pre-tax margin, and (ii) operating margins;
(h) Income, including (i) net income, and (ii) consolidated net income;
(i) Economic value added;
(j) Costs, including (i) operating or administrative expenses, (ii) operating expenses as a percentage of revenue, (iii) expense or cost levels, (iv) reduction of losses, loss ratios or expense ratios, (v) reduction in fixed costs, (vi) expense reduction levels, (vii) operating cost management, and (viii) cost of capital;
(k) Financial ratings, including (i) credit rating, (ii) capital expenditures, (iii) debt, (iv) debt reduction, (v) working capital, (vi) average invested capital, and (vii) attainment of balance sheet or income statement objectives;
(l) Market or category share, including (i) market share, (ii) volume, (iii) unit sales volume, and (iv) market share or market penetration with respect to specific designated products or product groups and/or specific geographic areas;
(m) Shareholder return, including (i) total shareholder return, (ii) shareholder return based on growth measures or the attainment of a specified share price for a specified period of time, and (iii) dividends; and
(n) Objective nonfinancial performance criteria measuring either (i) regulatory compliance, (ii) productivity and productivity improvements, (iii) inventory turnover, average inventory turnover or inventory controls, (iv) net asset turnover, (v) customer satisfaction based on specified objective goals or company-sponsored customer surveys, (vi) employee satisfaction based on specified objective goals or company-sponsored employee surveys, (vii) objective employee diversity goals, (viii) employee turnover, (ix) specified objective environmental goals, (x) specified objective social goals, (xi) specified objective goals in corporate ethics and integrity, (xii) specified objective safety goals, (xiii) specified objective business expansion goals or goals relating to acquisitions or divestitures, (xiv) day sales outstanding, and (xv) succession plan development and implementation.
A-6 |
Any one or more of the Management Objectives may be used on an absolute, relative or comparative basis to measure the performance, as the Committee may deem appropriate, or as compared to the performance of another company or a group of comparable companies, or published or special index that the Committee, in its sole discretion, deems appropriate, including various stock market indices.
2.29 Non-Employee Director means a Director who is a non-employee director within the meaning of Rule 16b-3.
2.30 Non-qualified Stock Option means an Option that by its terms does not qualify or is not intended to qualify as an Incentive Stock Option.
2.31 Option means an Incentive Stock Option or a Non-qualified Stock Option granted pursuant to Article IV of this Plan.
2.32 Other Share-Based Award means an Award granted pursuant to Article IX, which is payable in, valued in whole or in part by reference to, or otherwise based on or related to Common Shares, excluding any Option, Stock Appreciation Right, Restricted Share, Restricted Stock Unit, Performance Share or Performance Unit.
2.33 Participant means an Employee or Director who has been granted an Award under this Plan.
2.34 Performance Period means the one (1) or more periods of time (which shall not be less than one fiscal quarter in duration) as the Committee may select, over which the attainment of one or more Management Goals will be measured for purposes of determining a Participants right to and the payment of an Award subject to such Performance Period.
2.35 Performance Share means a bookkeeping entry that records the equivalent of one (1) Common Share awarded pursuant to Article VIII of this Plan.
2.36 Performance Unit means a bookkeeping entry that records a unit equivalent to $1.25 awarded pursuant to Article VIII of this Plan.
2.37 Person has the meaning provided in Section 2.6(a) of this Plan.
2.38 Related Rights has the meaning provided in Section 5.1 of this Plan.
2.39 Restricted Period has the meaning provided in Section 6.1 of this Plan.
2.40 Restricted Shares means Common Shares granted or sold pursuant to Article VI of this Plan.
2.41 Restricted Stock Unit means a bookkeeping entry that records the equivalent of one Common Share awarded pursuant to Article VII of this Plan.
2.42 Rule l6b-3 means Rule 16b-3 promulgated under the Exchange Act (or any successor rule to Rule 16b-3) as is in effect and may be amended from time to time.
A-7 |
2.43 Securities Act means the Securities Act of 1933, as amended, and the rules and regulations thereunder, as such law, rules and regulations may be amended from time to time.
2.44 Stock Appreciation Right means a right granted pursuant to Article V of this Plan.
2.45 Subsidiary means a corporation, company or other entity (i) more than fifty percent (50%) of whose outstanding shares or securities (representing the right to vote for the election of directors or other managing authority) are, or (ii) which does not have outstanding shares or securities (as may be the case in a partnership, joint venture or unincorporated association), but more than fifty percent (50%) of whose ownership interests representing the right generally to make decisions for such other entity is, now or hereafter, owned or controlled, directly or indirectly, by the Company except that for purposes of determining whether any person may be a Participant for purposes of a grant of Incentive Stock Options, Subsidiary means any corporation which is a subsidiary corporation, whether now or hereafter existing, as defined in Section 424(f) of the Code.
2.46 Ten Percent Shareholder means an employee of the Company, or of a parent or subsidiary corporation within the meaning of Section 424 of the Code, who owns (or is deemed to own pursuant to Section 424(d) of the Code) more than ten percent (10%) of the total combined voting power of all classes of voting stock of the Company, the Companys parent (if any) or any Subsidiary.
2.47 Voting Stock means at any time, the then-outstanding securities entitled to vote generally in the election of Directors.
ARTICLE III
SHARES SUBJECT TO THE PLAN
3.1 Number of Shares. Subject to adjustment as provided in Article XI of this Plan, the number of Common Shares that may be issued or transferred under this Plan shall not exceed in the aggregate 6,091,117 shares. Such shares may be shares of original issuance or treasury shares or a combination of the foregoing.
(a) Common Shares covered by an Award granted under this Plan will not be counted as used unless and until they are actually issued or transferred.
(b) If any Award is forfeited, expires, terminates, otherwise lapses or is settled for cash, in whole or in part, without the delivery of Common Shares, then the Common Shares covered by such forfeited, expired, terminated, lapsed or cash-settled Award shall again be available for grant under this Plan. In the event that withholding tax liabilities arising from an Award other than an Option or Stock Appreciation Right are satisfied by the tendering of Common Shares (either actually or by attestation) or by the withholding of Common Shares by the Company, the Common Shares so tendered or withheld shall be added to the Common Shares available for Awards under this Plan. For the avoidance of doubt, the following will not again become available for issuance under this Plan: (i) any Common Shares withheld in respect of taxes upon settlement of an Option or Stock Appreciation Right, (ii) any Common Shares tendered or withheld to pay an Exercise Price, (iii) any Common Shares subject to a Stock Appreciation Right that are not issued in connection with its stock settlement on exercise thereof, and (iv) any Common Shares reacquired by the Company on the open market or otherwise using cash proceeds.
A-8 |
3.2 Share Limits. Notwithstanding anything in this Article III or elsewhere in this Plan to the contrary, and subject to adjustments as provided in Article XI of this Plan, the limits specified below shall apply to any grants of the following types of Awards:
(a) Incentive Stock Options. Notwithstanding any designation of an Option as an Incentive Stock Option in an Award Agreement, to the extent the aggregate Fair Market Value of the Common Shares with respect to which the Incentive Stock Options are exercisable for the first time by the Participant during any calendar year (under all plans) exceeds one hundred thousand dollars ($100,000), the portion of the Options falling within such limit shall be Incentive Stock Options and the excess Options shall be treated as Non-qualified Stock Options. For these purposes, Incentive Stock Options shall be taken into account in the order in which they were granted, and the Fair Market Value of the Common Shares shall be determined as of the time the Option was granted. Incentive Stock Options covering no more than 6,091,117 Common Shares may be granted under this Plan.
(b) Non-Employee Director Limit. The aggregate dollar value of Awards granted to any non-Employee Director in any calendar year shall not exceed Seven Hundred and Fifty Thousand Dollars ($750,000). The value of the Awards shall be determined based on the Fair Market Value of each Award on the Date of Grant.
3.3 Minimum Vesting Requirements. Notwithstanding any provision of this Plan to the contrary, on and after the Effective Date, the Committee shall not award more than five percent (5%) of the aggregate number of Common Shares that become available for grant under this Plan as of the Effective Date pursuant to Awards that are solely subject to vesting conditions or performance periods that are less than one (1) year following the Date of Grant of the applicable Award, subject, in each case, to the Committees authority under this Plan to vest Awards earlier, as the Committee deems appropriate, upon the occurrence of a Change in Control, in the event of a Participants termination of employment or service or otherwise as permitted by this Plan.
ARTICLE IV
OPTIONS
4.1 Grant of Options. Subject to the limits of Sections 3.2 and 3.3 and the other terms and conditions of this Plan, the Committee may, from time to time and upon such terms and conditions as it may determine, grant Options to purchase Common Shares to Participants. Options granted under this Plan may be (i) Incentive Stock Options, (ii) Non-qualified Stock Options, or (iii) combinations of the foregoing. Incentive Stock Options may only be granted to Participants who meet the definition of employees under Section 3401(c) of the Code. Options granted under this Plan may not provide for any dividends or dividend equivalents thereon. Each such grant may utilize any or all of the authorizations, and shall be subject to all of the requirements, contained in the following provisions.
4.2 Award Agreement. Each Option shall be evidenced by an Award Agreement that shall specify the number of Common Shares covered by the Option, the Exercise Price of the Option, the term of the Option, whether the Option is intended to be an Incentive Stock Option, any conditions to the exercise of the Option, and such other terms and conditions as the Committee, in its discretion, determines and as are consistent with this Plan.
A-9 |
4.3 Exercise Price. Each grant shall specify an Exercise Price per share, which shall not be less than one hundred percent (100%) of the Fair Market Value on the Date of Grant; provided, however, that a Ten Percent Shareholder shall not be granted an Incentive Stock Option unless the Exercise Price per share is at least one hundred ten percent (110%) of the Fair Market Value on the Date of Grant and the Incentive Stock Option is not exercisable after expiration of five (5) years from the Date of Grant.
4.4 Exercise and Form of Consideration. To the extent exercisable, Options granted under this Plan shall be exercised by delivery of a written notice to the Company setting forth the number of Common Shares with respect to which the Option is being exercised, accompanied by full payment of the applicable Exercise Price. The Committee shall determine the acceptable form of consideration for the Exercise Price, including the method of payment, and for an Incentive Stock Option that determination shall be made at the time of grant. Consideration may consist of: (a) cash; (b) checks; (c) Common Shares, provided that such Common Shares have a Fair Market Value on the date of surrender equal to the aggregate Exercise Price and provided that accepting the Common Shares does not result in any adverse accounting consequences to the Company; (d) consideration received by the Company under a broker-assisted (or other) cashless exercise program implemented by the Company in connection with this Plan; (e) by net exercise; (f) other consideration and method of payment to the extent permitted by applicable law and approved by the Committee; or (g) any combination of the foregoing methods.
4.5 Related Rights. The exercise of an Option shall result in the cancellation on a share-for-share basis of any Related Rights authorized under Article V of this Plan.
4.6 Minimum Vesting Requirements. Subject to the exceptions stated in Section 3.3, no Award under this Article IV shall vest sooner than twelve (12) months from the Date of Grant.
4.7 Maximum Term. No Option shall be exercisable more than 10 years from the Date of Grant.
ARTICLE V
STOCK APPRECIATION RIGHTS
5.1 Grant of Stock Appreciation Rights. Subject to the limits of Sections 3.2 and 3.3 and the other terms and conditions of this Plan, the Committee may, from time to time and upon such terms and conditions as it may determine, grant Stock Appreciation Rights alone (Free Standing Rights) or in tandem with an Option granted under this Plan (Related Rights). Any Related Right that relates to a Non-qualified Stock Option may be granted at the same time the Option is granted or at any time thereafter but before the exercise or expiration of the Option. Any Related Right that relates to an Incentive Stock Option must be granted at the same time the Incentive Stock Option is granted. Stock Appreciation Rights granted under this Plan may not provide for any dividends or dividend equivalents thereon. Each such grant may utilize any or all of the authorizations, and shall be subject to all of the requirements, contained in the following provisions.
5.2 Award Agreement. Each Stock Appreciation Right shall be evidenced by an Award Agreement that shall describe such Stock Appreciation Right, the Exercise Price of the Stock Appreciation Right, the term of the Stock Appreciation Right, any conditions to the exercise of such Stock Appreciation Right, identify any related Option, and such other terms and conditions as the Committee, in its discretion, determines and as are consistent with this Plan.
A-10 |
5.3 Exercise Price. Each grant shall specify an Exercise Price for a Free Standing Right, which shall not be less than one hundred percent (100%) of the Fair Market Value on the Date of Grant. A Related Right shall have the same Exercise Price as the related Option, and shall be exercisable only to the same extent as the related Option.
5.4 Exercise and Form of Consideration. To the extent exercisable, Stock Appreciate Rights granted under this Plan shall be exercised by delivery of a written notice to the Company setting forth the number of Common Shares with respect to which the Stock Appreciation Right is being exercised, accompanied by full payment of the applicable Exercise Price. The Committee shall determine the acceptable form of consideration for the Exercise Price, including the method of payment. Consideration may consist of: (a) cash; (b) checks; (c) Common Shares, provided that such Common Shares have a Fair Market Value on the date of surrender equal to the aggregate Exercise Price and provided that accepting the Common Shares does not result in any adverse accounting consequences to the Company; (d) consideration received by the Company under a broker-assisted (or other) cashless exercise program implemented by the Company in connection with this Plan; (e) by net exercise; (f) other consideration and method of payment to the extent permitted by applicable law and approved by the Committee; or (g) any combination of the foregoing methods.
5.5 Payment. Upon exercise of a Stock Appreciation Right, the Participant shall be entitled to receive from the Company an amount equal to the number of Common Shares subject to the Stock Appreciation Right that is being exercised multiplied by the excess of the (i) Fair Market Value of a Common Share on the date the Award is exercised, over (ii) the Exercise Price specified in the Stock Appreciation Right or related Option. The grant shall specify whether the amount payable by the Company on exercise of the Stock Appreciation Right shall be paid in cash, in Common Shares or in any combination thereof and may either grant to the Participant or retain in the Committee the right to elect among those alternatives. Any grant may specify that the amount payable on exercise of a Stock Appreciation Right may not exceed a maximum specified by the Committee at the Date of Grant.
5.6 Minimum Vesting Requirements. Subject to the exceptions stated in Section 3.3, no Award under this Article V shall vest sooner than twelve (12) months from the Date of Grant.
5.7 Maximum Term. No Stock Appreciation Right shall be exercisable more than ten (10) years from the Date of Grant.
ARTICLE VI
RESTRICTED SHARES
6.1 Grant of Restricted Shares. Subject to the limits of Sections 3.2 and 3.3 and the other terms and conditions of this Plan, the Committee may, from time to time and upon such terms and conditions as it may determine, grant Restricted Shares to Participants. Each such grant shall provide that during the period for which substantial risk of forfeiture is to continue (the Restricted Period), the transferability of the Restricted Shares shall be prohibited or restricted in the manner and to the extent prescribed by the Committee at the Date of Grant (which restrictions may include, without limitation, rights of repurchase or first refusal in the Company or provisions subjecting the Restricted Shares to continuing substantial risk of forfeiture in the hands of any transferee). Each such grant may utilize any or all of the authorizations, and shall be subject to all of the requirements, contained in the following provisions.
A-11 |
6.2 Award Agreement. Each grant of Restricted Shares shall be evidenced by an Award Agreement that shall specify the number of Restricted Shares subject to the Award, the Restricted Period, any other conditions or restrictions on the Award, and such other terms and conditions as the Committee, in its discretion, determines and as are consistent with this Plan.
6.3 Rights. Each such grant shall constitute an immediate transfer of the ownership of Common Shares to the Participant in consideration of the performance of services, and unless otherwise determined by the Committee, entitling such Participant to voting, dividend and other ownership rights, subject to the substantial risk of forfeiture and the Restricted Period.
6.4 Certificates. Unless otherwise directed by the Committee, all certificates representing Restricted Shares shall be held in custody by the Company until all restrictions thereon shall have lapsed, together with a stock power executed by the Participant in whose name such certificates are registered, endorsed in blank and covering such Restricted Shares.
6.5 Minimum Vesting Requirements. Subject to the exceptions stated in Section 3.3, no Award under this Article VI shall vest sooner than twelve (12) months from the Date of Grant.
ARTICLE VII
RESTRICTED STOCK UNITS
7.1 Grant of Restricted Stock Units. Subject to the limits of Sections 3.2 and 3.3 and the other terms and conditions of this Plan, the Committee may, from time to time and upon such terms and conditions as it may determine, grant Restricted Stock Units to Participants. Each Restricted Stock Unit represents one (1) Common Share. Each such grant may utilize any or all of the authorizations, and shall be subject to all of the requirements, contained in the following provisions.
7.2 Award Agreement. Each grant of Restricted Stock Units shall be evidenced by an Award Agreement that shall specify the number of Restricted Stock Units subject to the Award, the Restricted Period, any other conditions or restrictions on the Award, and such other terms and conditions as the Committee, in its discretion, determines and as are consistent with this Plan.
7.3 Rights. No Common Shares shall be issued at the time a Restricted Stock Unit is granted, and a Participant shall have no voting rights with respect thereto. Restricted Stock Units shall be subject to forfeiture until the expiration of the Restricted Period and satisfaction of any applicable conditions, including vesting time periods or performance requirements, to the extent provided in the applicable Award Agreement.
7.4 Dividend Equivalents. At the discretion of the Committee, each Restricted Stock Unit may be credited with dividend equivalents or other equivalent distributions. Dividend equivalents or other equivalent distributions shall be paid on a current basis unless the Award Agreement requires otherwise; provided, however dividend equivalents or other equivalent distributions on Restricted Stock Units that are subject to performance requirements, including Management Goals, shall be deferred until and paid contingent upon the level of achievement of the applicable performance or Management Goals at the end of the related Performance Period.
7.5 Payment. Each grant shall specify the time and manner of payment of Restricted Stock Units. Any grant may specify that the amount payable with respect thereto may be paid by the Company in cash, in
A-12 |
Common Shares or in any combination thereof and may either grant to the Participant or retain in the Committee the right to elect among those alternatives.
7.6 Minimum Vesting Requirements. Subject to the exceptions stated in Section 3.3, no Award under this Article VII shall vest sooner than twelve (12) months from the Date of Grant.
ARTICLE VIII
PERFORMANCE UNITS AND PERFORMANCE SHARES
8.1 Grant of Performance Shares and Performance Units. Subject to the limits of Sections 3.2 and 3.3 and the other terms and conditions of this Plan, the Committee may, from time to time and upon such terms and conditions as it may determine, grant Performance Shares and Performance Units to Participants that will become payable upon achievement of specified performance goals, which may include Management Goals. Each such grant may utilize any or all of the authorizations, and shall be subject to all of the requirements, contained in the following provisions.
8.2 Award Agreement. Each grant of Performance Shares or Performance Units shall be evidenced by an Award Agreement that shall specify the number of Performance Shares or Performance Units subject to the Award, the performance objectives (which may include Management Goals), the Performance Period applicable to the Award, any other conditions or restrictions on the Award, and such other terms and conditions as the Committee, in its discretion, determines and as are consistent with this Plan.
8.3 Performance Objectives. Any grant of Performance Shares or Performance Units shall specify the performance objectives, which may include Management Goals, which, if achieved, will result in payment or early payment of the Award. Each grant may specify a minimum acceptable level of achievement of the performance objectives and shall set forth a formula for determining the number of Performance Shares or Performance Units that will be earned if performance is at or above the minimum level, but falls short of full achievement of the specified performance objectives. Before the Performance Shares or Performance Units shall be earned and paid, the Committee must determine the level of achievement of the performance objectives.
8.4 Dividends and Dividend Equivalents. The Committee may, at the Date of Grant of Performance Shares or Performance Units, provide for the payment of dividends or dividend equivalents to the Participant thereof either in cash or in additional Common Shares, subject in all cases to deferral and payment on a contingent basis based on the Participants earning of the Performance Shares or Performance Units with respect to which such dividend equivalents are paid.
8.5 Payment. Each grant shall specify the time and manner of payment of Performance Shares or Performance Units which have been earned. Any grant may specify that the amount payable with respect thereto may be paid by the Company in cash, in Common Shares or in any combination thereof and may either grant to the Participant or retain in the Committee the right to elect among those alternatives.
8.6 Minimum Vesting Requirements. Subject to the exceptions stated in Section 3.3, no Award under this Article VIII shall have a Performance Period of less than twelve (12) months from the Date of Grant.
A-13 |
ARTICLE IX
OTHER SHARE-BASED AWARDS
9.1 Grant of Other Share-Based Awards. Subject to the limits of Sections 3.2 and 3.3 and the other terms and conditions of this Plan, the Committee may, from time to time and upon such terms and conditions as it may determine, grant Other Share-Based Awards not otherwise described by the terms of this Plan to Participants. Such Awards may involve the transfer of actual Common Shares to Participants and may include Awards designed to comply with or take advantage of applicable local laws of jurisdictions other than the United States. Each Other Share-Based Award will be expressed in terms of Common Shares or units based on Common Shares. Each such grant may utilize any or all of the authorizations, and shall be subject to all of the requirements, contained in the following provisions.
9.2 Award Agreement. Each grant of an Other Share-Based Award shall be evidenced by an Award Agreement that will specify the number of Common Shares or units covered by the Award, any conditions related to the Award, and such other terms and conditions as the Committee, in its discretion, determines and as are consistent with this Plan.
9.3 Payment. Payment, if any, with respect to an Other Share-Based Award, will be made in accordance with the terms of the Award, in cash, in Common Shares or a combination of both as determined by the Committee.
9.4 Minimum Vesting Requirements. Subject to the exceptions stated in Section 3.3, no Award under this Article IX shall vest sooner than twelve (12) months from the Date of Grant.
ARTICLE X
TRANSFERABILITY
10.1 Transfer Limits. Except as otherwise determined by the Committee, no Options, Stock Appreciation Right or other derivative security granted under this Plan shall be transferable by a Participant other than by will or the laws of descent and distribution, except (in the case of a Participant who is not a Director or officer of the Company) to a fully revocable trust of which the holder is treated as the owner for federal income tax purposes, and in no event will any such Award granted under this Plan be transferred for value. Except as otherwise determined by the Committee, Options and Stock Appreciation Rights shall be exercisable during the Participants lifetime only by him or her or by his or her guardian or legal representative. Notwithstanding the foregoing, the Committee in its sole discretion may provide for transferability of Options and Stock Appreciation Rights under this Plan so long as such provisions will not disqualify the exemption for other awards under Rule 16b-3 and so long as such transfer is not to a third-party entity, including financial institutions.
10.2 Further Restrictions. The Committee may specify at the Date of Grant that part or all of the Common Shares that are (i) to be issued or transferred by the Company upon the exercise of Options or Stock Appreciation Rights or upon payment under any grant of Performance Shares, Performance Units, Restricted Stock Units or Other Share-Based Awards or (ii) no longer subject to the substantial risk of forfeiture and restrictions on transfer referred to in Article VI of this Plan, shall be subject to further restrictions on transfer.
A-14 |
ARTICLE XI
ADJUSTMENTS
The Committee shall make or provide for such adjustments in the numbers of Common Shares covered by outstanding Awards granted hereunder, in the prices per share applicable to such Options and Stock Appreciation Rights and in the kind of shares covered thereby, as the Board, in its sole discretion, exercised in good faith, may determine is equitably required to prevent dilution or enlargement of the rights of Participants that otherwise would result from (a) any stock dividend, stock split, combination of shares, recapitalization or other change in the capital structure of the Company, or (b) any merger, consolidation, spin-off, split-off, spin-out, split-up, reorganization, partial or complete liquidation or other distribution of assets, issuance of rights or warrants to purchase securities, or (c) any other corporate transaction or event having an effect similar to any of the foregoing. Moreover, in the event of any such transaction or event, the Committee, in its discretion, may provide in substitution for any or all outstanding Awards under this Plan such alternative consideration as it, in good faith, may determine to be equitable in the circumstances and may require in connection therewith the surrender of all Awards so replaced. In addition, for each Option or Stock Appreciation Right with an Exercise Price greater than the consideration offered in connection with any such transaction or event or Change in Control, the Committee may in its sole discretion elect to cancel such Option or Stock Appreciation Right without any payment to the person holding such Option or Stock Appreciation Right. The Committee may also make or provide for such adjustments in the numbers of shares specified in Section 3.2 of this Plan as the Committee in its sole discretion, exercised in good faith, may determine is appropriate to reflect any transaction or event described in this Article XI.
ARTICLE XII
TAX WITHHOLDING
To the extent that the Company is required to withhold federal, state, local or foreign taxes in connection with any payment made or benefit realized by a Participant or other person under this Plan, and the amounts available to the Company for such withholding are insufficient, it shall be a condition to the receipt of such payment or the realization of such benefit that the Participant or such other person make arrangements satisfactory to the Company for payment of the balance of such taxes required to be withheld, which arrangements (in the discretion of the Committee) may include relinquishment of a portion of such benefit. Participants shall also make such arrangements as the Company may require for the payment of any withholding tax obligations that may arise in connection with the disposition of shares acquired upon the exercise of Options. In no event, however, shall the Company accept Common Shares for payment of taxes in excess of required tax withholding rates (or, after the Companys adoption of ASU 2016-09, Compensation-Stock Compensation (Topic 718) dated March, 2016, in excess of maximum applicable tax rates), except that, in the discretion of the Committee, a Participant or such other person may surrender Common Shares owned for more than six (6) months to satisfy any tax obligations resulting from any such transaction.
ARTICLE XIII
SUBSIDIARIES AND NON-US JURISDICTIONS
13.1 Participation by Employees of Designated Subsidiaries. As a condition to the effectiveness of any grant or Award to be made hereunder to a Participant who is an employee of a Designated Subsidiary, whether or not such Participant is also employed by the Company or another Subsidiary, the Committee
A-15 |
may require such Designated Subsidiary to agree to transfer to such employee (when, as and if provided for under this Plan and any applicable agreement entered into with any such employee pursuant to this Plan) the Common Shares that would otherwise be delivered by the Company, upon receipt by such Designated Subsidiary of any consideration then otherwise payable by such Participant to the Company. Any such award shall be evidenced by an agreement between the Participant and the Designated Subsidiary, in lieu of the Company, on terms consistent with this Plan and approved by the Committee and such Designated Subsidiary. All such Common Shares so delivered by or to a Designated Subsidiary shall be treated as if they had been delivered by or to the Company for purposes of Article III of this Plan, and all references to the Company in this Plan shall be deemed to refer to such Designated Subsidiary, except for purposes of the definition of Board and Committee and except in other cases where the context otherwise requires.
13.2 Employees Outside the US. In order to facilitate the making of any grant or combination of grants under this Plan, the Committee may provide for such special terms for Awards to Participants who are foreign nationals or who are employed by the Company or any Subsidiary outside of the United States of America as the Committee may consider necessary or appropriate to accommodate differences in local law, tax policy or custom. Moreover, the Committee may approve such supplements to or amendments, restatements or alternative versions of this Plan as it may consider necessary or appropriate for such purposes, without thereby affecting the terms of this Plan as in effect for any other purpose, and the Secretary or other appropriate officer of the Company may certify any such document as having been approved and adopted in the same manner as this Plan. No such special terms, supplements, amendments or restatements, however, shall include any provisions that are inconsistent with the terms of this Plan as then in effect unless this Plan could have been amended to eliminate such inconsistency without further approval by the shareholders of the Company.
ARTICLE XIV
ADMINISTRATION
14.1 Delegation to Committee. The Board hereby delegates authority to administer this Plan to the Compensation Committee of the Board (or its successor(s)), or any other committee of the Board hereafter designated by the Board to administer this Plan, and the term Committee shall apply to any persons to whom such power is delegated. The Committee described in this Section 14.1 may from time to time delegate all or any part of its authority under this Plan to a subcommittee thereof (to the extent of any such delegation, references in this Plan to the Committee will be deemed to be references to such subcommittee). A majority of the Committee (or subcommittee thereof) shall constitute a quorum, and the action of the members of the Committee (or subcommittee thereof) present at any meeting at which a quorum is present, or acts unanimously approved in writing, shall be the acts of the Committee (or subcommittee thereof).
14.2 Committee Requirements. Except as otherwise determined by the Board, the Committee shall consist solely of two (2) or more Non-Employee Directors. The Board shall have discretion to determine whether it intends to comply with the exemption requirements of Section 16b-3 of the Code. However, if the Board intends to satisfy such exemption requirements, with respect to any insider subject to Section 16 of the Exchange Act, the Committee shall be a compensation committee of the Board that at all times consists solely of two (2) or more Non-Employee Directors. Within the scope of that authority, the Board or the Committee may delegate to a committee of one (1) or more members of the Board who are not Non-Employee Directors the authority to grant Awards to eligible persons who are not then subject to Section 16 of the Exchange Act. Nothing herein shall create an inference that an Award is not validly
A-16 |
granted under this Plan in the event Awards are granted under this Plan by a Committee that does not at all times consist solely of two (2) or more Non-Employee Directors.
14.3 Interpretation. The interpretation and construction by the Committee of any provision of this Plan or of any Award Agreement and any determination by the Committee pursuant to any provision of this Plan or of any such Award Agreement, notification or document shall be final and conclusive. No member of the Board or the Committee shall be liable for any such action or determination made in good faith.
14.4 Companys Rights Upon Occurrence of Detrimental Activity. Any Award Agreement may provide (whether or not such would result in additional tax to a Participant under Section 409A of the Code) that if a Participant, either during employment by the Company or a Subsidiary or within a specified period after termination of such employment, shall engage in any Detrimental Activity, and the Board shall so find, forthwith upon notice of such finding, the Participant shall, unless otherwise provided in the Award Agreement:
(a) Return to the Company, in exchange for payment by the Company of any amount actually paid therefor by the Participant, all Common Shares that the Participant has not disposed of that were offered pursuant to this Plan within a specified period prior to the date of the commencement of such Detrimental Activity, and
(b) With respect to any Common Shares so acquired that the Participant has disposed of, pay to the Company in cash the difference between: (i) any amount actually paid therefor by the Participant pursuant to this Plan, and (ii) the Fair Market Value of the Common Shares on the date of such acquisition.
To the extent that such amounts are not paid to the Company, the Company may set off the amounts so payable to it against any amounts (but only to the extent that such amount would not be considered nonqualified deferred compensation within the meaning of Section 409A of the Code) that may be owing from time to time by the Company or a Subsidiary to the Participant, whether as wages, deferred compensation or vacation pay or in the form of any other benefit or for any other reason.
14.5 Clawback. Notwithstanding any other provisions in this Plan, any Award which is subject to recovery under any law, government regulation or stock exchange listing requirement (or any policy adopted by the Company pursuant to any of the foregoing) will be subject to such deductions and clawback as may be required or permitted to be made pursuant to such law, government regulation, stock exchange listing requirement or policy (or pursuant to any other policy adopted by the Company at the direction of the Board, including the Companys current clawback policy).
14.6 Compliance with Section 409A of the Code. To the extent applicable, it is intended that this Plan and any grants made hereunder comply with the provisions of Section 409A of the Code. This Plan and any grants made hereunder shall be administered in a manner consistent with this intent.
14.7 Fractional Shares. The Company shall not be required to issue any fractional Common Shares pursuant to this Plan. The Committee may provide for the elimination of fractions or for the settlement of fractions in cash.
A-17 |
ARTICLE XV
AMENDMENT AND TERMINATION
15.1 Amendment or Termination Authority. The Company, by action of the Board (or its designee), may at any time and from time to time amend or terminate this Plan in whole or in part. Any amendment which must be approved by the shareholders of the Company in order to comply with applicable law or the rules of any national securities exchange upon which the Common Shares are traded or quoted shall not be effective unless and until such approval has been obtained. Presentation of this Plan or any amendment thereof for shareholder approval shall not be construed to limit the Companys authority to offer similar or dissimilar benefits in plans that do not require shareholder approval. Any amendment or termination of this Plan shall not impair in any material way the rights or obligations of any Participant under any Award that is outstanding as of the effective date of the amendment or termination without the written consent of the Participant. The Committee shall maintain its right to exercise its authority under this Plan with respect to any outstanding Awards at the effective date of termination.
15.2 Deferrals. Except with respect to Options and Stock Appreciation Rights, the Committee may permit Participants to elect to defer the issuance of Common Shares or the settlement of awards in cash under this Plan pursuant to such rules, procedures or programs as it may establish for purposes of this Plan and which are intended to comply with the requirements of Section 409A of the Code. The Committee also may provide that deferred settlements include the payment or crediting of dividend equivalents or interest on the deferral amounts.
15.3 Conditions. The Committee may condition the grant of any Award or combination of Awards authorized under this Plan on the surrender or deferral by the Participant of his or her right to receive a cash bonus or other compensation otherwise payable by the Company or a Subsidiary to the Participant.
15.4 Special Circumstances. If permitted by Section 409A of the Code in case of termination of employment by reason of death, Disability or normal or early retirement, or in the case of hardship or other special circumstances, of a Participant who holds Options or Stock Appreciation Rights not immediately exercisable in full, or any Restricted Shares or Restricted Stock Units as to which the substantial risk of forfeiture or the prohibition or restriction on transfer has not lapsed, or any Performance Shares or Performance Units which have not been fully earned, or Other Share-Based Awards subject to restrictions or conditions, the Committee may, in its sole discretion, accelerate the time at which such Options or Stock Appreciation Rights may be exercised, or the time at which such substantial risk of forfeiture or prohibition or restriction on transfer will lapse for Restricted Shares or Restricted Units, or the time at which such Performance Shares or Performance Units will be deemed to have been fully earned, or the time when such restrictions or conditions will terminate with respect to Other or Share-Based Awards, or may waive any other limitation or requirement under any such Award.
15.5 Change in Exercise Price Prohibited. Except in connection with a corporate transaction or event described in Article XI of this Plan, the terms of outstanding Awards may not be amended to reduce the Exercise Price of outstanding Options or Stock Appreciation Rights, or cancel outstanding Options or Stock Appreciation Rights in exchange for cash, other awards or Options or Stock Appreciation Rights with an Exercise Price that is less than the Exercise Price of the original Option Stock Appreciation Right, as applicable, without shareholder approval.
A-18 |
15.6 No Right to Continued Employment. This Plan shall not confer upon any Participant any right with respect to continuance of employment or other service with the Company or any Subsidiary, nor shall it interfere in any way with any right the Company or any Subsidiary would otherwise have to terminate such Participants employment or other service at any time. Prior to exercise of any Option, and prior to exercise, payment or delivery pursuant to any other Award, the Participant may be required, at the Companys request, to certify in a manner reasonably acceptable to the Company that the Participant has not engaged in, and has no present intention to engage in the future in, any Detrimental Activity.
15.7 Incentive Stock Options. To the extent that any provision of this Plan would prevent any Option that was intended to qualify as an Incentive Stock Option from qualifying as such, that provision shall be null and void with respect to such Option. Such provision, however, shall remain in effect for other Options and there shall be no further effect on any provision of this Plan.
ARTICLE XVI
GOVERNING LAW
This Plan and all Awards granted and actions taken thereunder shall be governed by and construed in accordance with the internal substantive laws of the State of Ohio, without regard to conflicts of law principles thereof.
A-19 |
Directions to Courtyard Marriott
4375 Metro Circle NW, North Canton, Ohio 44720
From Akron-Canton Regional Airport
Take Interstate 77 South to the Everhard Road Exit. Turn right onto Everhard Road NW. Take the first right onto Dressler Road NW. Take the first right onto Metro Circle NW. The hotel is located on the left.
From Youngstown (East)
Take Interstate 76 West to Interstate 77 South. Proceed on Interstate 77 South to the Everhard Road Exit. Turn right onto Everhard Road NW. Take the first right onto Dressler Road NW. Take the first right onto Metro Circle NW. The hotel is located on the left.
From Cleveland Hopkins International Airport
Take Route 71 South to the Ohio Turnpike (80 East). Proceed on the Ohio Turnpike to Exit 180 (Route 8 South). Continue on Route 8 South to Interstate 77 South. Proceed on Interstate 77 South to the Everhard Road Exit. Turn right onto Everhard Road NW. Take the first right onto Dressler Road NW. Take the first right onto Metro Circle NW. The hotel is located on the left.
From Columbus (West)
Take Interstate 71 North to Interstate 76/224 East. Continue for approximately 20 miles to Interstate 77 South. Proceed on Interstate 77 South to the Everhard Road Exit. Turn right onto Everhard Road NW. Take the first right onto Dressler Road NW. Take the first right onto Metro Circle NW. The hotel is located on the left.
DIEBOLD NIXDORF, INCORPORATED 5995 MAYFAIR ROAD P.O. BOX 3077 NORTH CANTON, OH 44720-8077 |
VOTE BY INTERNET - www.proxyvote.com | |||
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. | ||||
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS | ||||
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. | ||||
VOTE BY PHONE - 1-800-690-6903 | ||||
Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. | ||||
VOTE BY MAIL | ||||
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. |
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: | ||
E40444-P02687 KEEP THIS PORTION FOR YOUR RECORDS | ||
DETACH AND RETURN THIS PORTION ONLY |
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
DIEBOLD NIXDORF, INCORPORATED | ||||||||||||||||||||||||
The Board of Directors recommends you vote FOR each of the following nominees: | ||||||||||||||||||||||||
1. | Election of Directors | For | Against | Abstain | ||||||||||||||||||||
Nominees: | ||||||||||||||||||||||||
1a. Patrick W. Allender | ☐ | ☐ | ☐ | |||||||||||||||||||||
1b. Phillip R. Cox | ☐ | ☐ | ☐ | The Board of Directors recommends you vote FOR proposals 2-4: | For | Against | Abstain | |||||||||||||||||
1c. Richard L. Crandall | ☐ | ☐ | ☐ | 2. | To ratify the appointment of KPMG LLP as our independent registered public accounting firrm for the year ending December 31, 2018 | ☐ | ☐ | ☐ | ||||||||||||||||
1d. Dr. Alexander Dibelius | ☐ | ☐ | ☐ | 3. | To approve, on an advisory basis, named executive officer compensation | ☐ | ☐ | ☐ | ||||||||||||||||
1e. Dr. Dieter W. Düsedau | ☐ | ☐ | ☐ | 4. | To approve amendments to the Diebold Nixdorf, Incorporated 2017 Equity and Performance Incentive Plan | ☐ | ☐ | ☐ | ||||||||||||||||
1f. Gale S. Fitzgerald | ☐ | ☐ | ☐ | |||||||||||||||||||||
1g. Gary G. Greenfield | ☐ | ☐ | ☐ | |||||||||||||||||||||
1h. Gerrard B. Schmid | ☐ | ☐ | ☐ | |||||||||||||||||||||
1i. Rajesh K. Soin | ☐ | ☐ | ☐ | |||||||||||||||||||||
1j. Alan J. Weber | ☐ | ☐ | ☐ | |||||||||||||||||||||
1k. Dr. Juergen Wunram | ☐ | ☐ | ☐ | |||||||||||||||||||||
NOTE: The Common Shares represented by this proxy will be voted by the Proxy Committee, as recommended by the Board of Directors, unless otherwise specified. | ||||||||||||||||||||||||
Please sign exactly as your name appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, trustee or guardian, please give your full title as such. |
Signature [PLEASE SIGN WITHIN BOX] | Date |
Signature (Joint Owners) |
Date |
PLEASE VOTE TODAY
SEE REVERSE SIDE
FOR THREE EASY WAYS TO VOTE!
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Annual Report, Notice & Proxy Statement is/are available at www.proxyvote.com.
E40445-P02687
DIEBOLD NIXDORF, INCORPORATED
This Proxy is Solicited on Behalf of the Board of Directors
The undersigned hereby appoints Gerrard B. Schmid and Christopher A. Chapman, and each of them, as the Proxy Committee, with full power of substitution, to represent and to vote all the Common Shares of Diebold Nixdorf, Incorporated held of record by the undersigned on February 26, 2018, at the Annual Meeting of Shareholders which will be held at the Courtyard Marriott, 4375 Metro Circle NW, North Canton, Ohio 44720 (directions available in the Proxy Statement) on April 25, 2018 at 11:30 a.m. EDT, or at any adjournment or postponement thereof, as indicated on the reverse side. This proxy card also constitutes your voting instructions for any and all shares held of record by Equiniti Trust Company for the account in the Dividend Reinvestment Plan.
This proxy covers all shares for which the undersigned has the right to give voting instructions to Bank of America Merrill Lynch, Trustee of the DIEBOLD NIXDORF, INCORPORATED 401(K) SAVINGS PLAN #610146 and the DIEBOLD NIXDORF, INCORPORATED 401(K) SAVINGS PLAN FOR PUERTO RICO ASSOCIATES #610147. This proxy, when properly executed, will be voted as directed. If no direction is given to the Trustee by 5:30 p.m. EDT on April 23, 2018 the Trustee will vote these shares held in the Plans.
You are encouraged to specify your choices by marking the appropriate boxes, SEE REVERSE SIDE, but you need not mark any boxes if you wish to vote in accordance with the Board of Directors' recommendations. The Proxy Committee cannot vote the shares unless you sign and return this proxy card. In its discretion, the Proxy Committee is authorized to vote upon such other business as may properly come before the meeting.
Continued and to be signed on reverse side
|